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ABSTRACT OF DISSERTATION 
 
 
THROMBOLYSIS AND EARLY SPEECH AND LANGUAGE  
RECOVERY AFTER STROKE 
 
Speech and language impairments after left hemisphere stroke are life altering. 
Neuroprotective interventions, such as tissue plasminogen activator, or tPA, are utilized to 
diminish the impact of the stroke on functional ability. 
The purpose of this study was to examine speech and language recovery in the first 
three months after stroke in individuals with aphasia and to further investigate any 
differences between individuals who did and individuals who did not receive tPA, using 
objective speech and language measures.  
Twenty-six individuals, thirteen of whom received tPA and thirteen who did not, 
suffering from first-ever left hemisphere stroke with resulting aphasia were enrolled and 
completed repeated speech and language assessments within 24 hours after stroke, at one 
and two weeks after stroke. A three month assessment also included an additional quality 
of life measure.  
Findings indicate that both individuals who did and those who did not receive tPA 
demonstrated significant gains in language skills. Results also suggest that the individuals 
who received tPA have better outcomes at three months compared to those who did not. 
This is clinically significant as it helps provide prognostic information about the use of tPA 
and informs decision making for speech pathologists within the acute care hospital. 
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Chapter One- Introduction 
 
Overview 
 
Stroke is a leading cause of disability and death throughout the world. While the 
incidence of new strokes has remained stable, death rates have decreased over the last 10-
15 years (Benjamin et al, 2017). As a result, more individuals are living out their lives 
coping with and being treated for residual effects of a stroke. Considering the financial 
impact on the healthcare economy, the American Stroke Association (ASA; Benjamin et 
al, 2017) estimated the total direct cost of care for stroke in the United States in 2013 was 
$17.9 billion, with a mean expense per patient of $5,232. The ASA (Benjamin et al, 
2017) also projected that America would spend $1.5 trillion in stroke care between the 
years 2005-2050, with many of these dollars spent on rehabilitation of individuals 
recovering from stroke. As such, it is important to focus attention on the efficacy of 
current clinical practices intended to minimize the disabling consequences of stroke. 
An estimated 800,000 individuals experience a cerebrovascular accident each 
year, with 610,000 of these being first-time strokes (Benjamin et al, 2017). Ischemic 
strokes, often created by clots that either form at the location of the stroke or travel from 
elsewhere in the body, account for 87% of all strokes. The remaining 13% are 
hemorrhagic, occurring when a blood vessel ruptures and bleeds into the brain (Benjamin 
et al, 2017). Because ischemic strokes damage the brain differently than hemorrhages, 
these two types of strokes have different prognoses and clinical treatment pathways.  
Aphasia, an acquired language disorder affecting input and output modalities 
resulting from damage to the brain’s language dominant hemisphere, is a frequent 
2 
  
consequence of ischemic stroke (Brookshire, 2007). Aphasia is often accompanied by 
neuromotor speech disorders such as apraxia of speech and unilateral upper motor neuron 
dysarthria (Wambaugh & Shuster, 2008) that further compromise a person’s 
communicative ability. Aphasia is present in 15-30% of individuals with stroke at time of 
admission to the acute care hospital (Engleter et al, 2006; Inatomi, et al, 2008; Laska, 
Hellblom, Murray, Kahan, & Von Arbin, 2001; Lazar et al, 2010; Maas et al 2012) and 
its consequences are frequently long term. Studies using objective language tests reveal 
that the majority of people with aphasia never completely recover their pre-morbid 
communicative abilities (Klebic, Salihovic, Softic, & Solihovic, 2001; Laska et al, 2001).  
In addition to the impact on an individual’s receptive and expressive language skills, 
aphasia has profound functional, psychosocial, and emotional consequences for patients 
and families. These include activity limitations such as inability to participate in 
conversations, make phone calls, respond to emails, read the paper and carry out other 
tasks considered normal in one’s culture (Elman, 1994; Kagan & Gailey, 1993; Kagan, 
1998), participation restrictions reflected in abandonment of formerly enjoyed activities, 
fewer social contacts (Cruice, Worrall, & Hickson, 2006; Dalesman et al., 2008), and 
strained interpersonal relationships (Croteau, LeDorze, & Morin, 2008; Doyle, McNeill, 
Hula, & Mikolic, 2003; Michallet, Tretreault, & LeDorze, 2003; Simmons-Mackie, 
Kearns, & Potechin, 2005). Researchers have also reported people with aphasia and their 
families have a reduced quality of life and can suffer from depression, loss of confidence, 
and reduced self-esteem (Shadden, Hagstron, & Koski, 2008; Simmons-Mackie, King, & 
Beukelman, 2013).  
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Scientists have continually sought to develop treatments that would minimize 
and/or prevent neurological damage resulting from a stroke thereby reducing the 
disabling consequences of conditions such as aphasia. Pharmacological and procedural 
interventions have been implemented clinically by physicians as an early treatment for 
ischemic strokes. The aim of these treatments is to improve clinical outcomes and reduce 
functional impairment by restoring vascularization to the brain, potentially preventing 
tissue damage. One such neuro-protective intervention is administration of intravenous 
tissue plasminogen activator (tPA), using the mechanism of thrombolysis, or breaking up 
clots. tPA is intended to dissolve the blood clot to help restore blood flow through the 
vessel and hopefully, limit damage to brain tissue.  Since its approval for use by the U. S. 
Food and Drug Administration (FDA) in 1996, tPA has been receiving more widespread 
clinical use (Fang, Cutler, & Rosen, 2010).  
tPA is administered only under specific conditions. Due to the risk of hemorrhage 
with tPA, it is used solely with ischemic type strokes. Moreover, the benefits of tPA are 
known to be maximized if it is administered during a small window of time. Initially, the 
time window set for administration of tPA by the FDA was three hours after stroke 
symptom onset. More recently, clinical trials suggest this window can be expanded to 4.5 
hours for certain eligible patients (Cheng & Kim, 2015; NINDS, 1995; Hacke et al, 1995; 
Hacke et al, 1998; Hacke et al, 2008; Clark et al, 1999; Clark, Albers, Madden, & 
Hamilton, 2000). While national rates of tPA are slowly increasing, administration 
remains low (Benjamin et al, 2017). In part, this is due to the short time frame for 
administering tPA, not seeking medical attention for symptoms of a stroke until after the 
time frame has elapsed (Eissa, Krass, Levi, Sturm, Ibrahim, & Bajorek, 2013; Maze & 
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Bakas, 2004), geography, and seeking early treatment at smaller hospitals where tPA is 
not available (Adeoye, Hornung, Khatri, & Kleindorfer, 2011; Benjamin et al, 2017). In 
hospital systems with dedicated stroke units and stroke programs, however, 
administration rates of tPA reportedly range from 15-38% (Cheng & Kim, 2015; 
Lichtman et al, 2009).  Interestingly, utilization has continued to be low, even after the 
expansion of the time window to 4.5 hours.  
Research on the effects of tPA on clinical outcomes for survivors of ischemic 
stroke is ongoing and will be reviewed in Chapter 2. Currently, it is not clear if tPA 
significantly impacts clinical outcomes for individuals with ischemic stroke, regardless of 
whether or not these individuals manifest aphasia. There are multiple challenges faced by 
researchers seeking to conduct prospective studies on the effects of tPA on outcomes for 
ischemic stroke survivors. With the cascade of events that accompany a new stroke, it is 
difficult to objectively assess patients shortly after onset of stroke and arrival at the 
emergency room. Barriers within the acute care hospital such as patient access, urgency 
of medical intervention, reduced length of stay associated with a trend to discharge 
patients as soon as possible, and spontaneous recovery of deficits have precluded 
rigorous study in this area.   
  The goal of this study was to examine and compare expressive speech and 
language changes for patients with first-time ischemic stroke with aphasia who did and 
did not receive tPA.  Aphasia was selected as a target symptom to study the effects of 
tPA for three reasons. First, patients who demonstrate overt signs of aphasia in the ER 
after ischemic stroke are likely to receive tPA (Dickey et al, 2010; Di Legge, Fang, 
Saposnik, & Hachinski, 2005; Engelter et al, 2006; Kohrmann et al, 2008; Maas et al, 
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2012). Secondly, aphasia frequently accompanies a left hemisphere ischemic stroke and 
is a source of long-term disablement for many patients. Any treatment that potentially 
reduces the severity of conditions such as aphasia warrants careful study, particularly a 
treatment that costs $6,000-7,000 to provide (Mozzaffarian et al, 2016). Finally, the 
primary investigator is a Speech-Language Pathologist, Director of the Chandler Medical 
Center Speech-Language Pathology Services, and member of the Stroke Care Team and 
has a vested interest in improving and developing contemporary assessment and 
treatment procedures for patients with aphasia from stroke in the acute care hospital.  
 
Primary Research Questions 
 
Question 1: Do persons with aphasia following a first-ever left hemisphere ischemic 
stroke improve speech and language skills in the first two weeks post onset? 
Hypothesis: Individuals with speech and language deficits after first-ever left 
hemisphere stroke will perform significantly better on speech and language tasks over 
multiple time points during the first two weeks after stroke. The null hypothesis is that the 
participants will make no significant improvement over two weeks on verbal output 
measures, specifically repetition of digits, polysyllabic words, confrontational picture 
naming, and picture description. 
 
Question 2: Do persons with aphasia following a first-ever left hemisphere ischemic 
stroke who do and do not receive tPA exhibit differences in speech and language 
recovery in the first two weeks post onset? 
6 
  
Hypothesis: Individuals who receive tPA will perform significantly better on objective 
speech and language measures in the first two weeks post-onset than those who do not 
receive tPA. The null hypothesis is that there will be no difference between individuals 
who do and do not receive tPA on verbal output measures, specifically repetition of 
digits, polysyllabic words, confrontational picture naming, and picture description. 
 
Question 3: Do persons with aphasia resulting from a first-ever ischemic stroke who do 
and do not receive tPA differ on speech, language, and quality of life measures at three 
months after stroke after receiving speech and language therapy?  
Hypothesis: Individuals who receive tPA will perform significantly better on each 
objective measure at three months compared to those who do not receive tPA. In 
addition, individuals who receive tPA will have significantly better quality of life, as 
indicated by a higher score on the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-
39), compared to those who did not receive tPA. The null hypothesis is that there will be 
no difference between individuals who do and do not receive tPA on verbal output 
measures, specifically repetition of digits, polysyllabic words, confrontational picture 
naming, and picture description or the SAQOL-39 at 3 months post stroke. 
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Secondary Research Question 
Question 4: In persons with first-ever left hemisphere stroke resulting in speech and 
language deficits, what other relationships are present between demographic, medical, 
and therapeutic variables and early speech and language recovery? 
Hypothesis: The following variables will be significant predictors of early speech and 
language recovery following first-ever left hemisphere stroke: age, education, gender, 
location of stroke, comorbidity index, current medications, stroke severity, and amount of 
speech language therapy received. The null hypothesis is that no variables tested will 
significantly predict speech and language recovery. 
  
This study is important and unique in several ways. To the knowledge of the 
investigator, it is the first prospective study to examine speech and language changes in 
individuals who do and do not receive tPA in a systematic fashion. To date, benefits of 
tPA on speech and language outcomes have been assumed or examined retrospectively in 
individual subjects or studies with small sample sizes (Ness, 2012; Cho 2015; Mazza 
2012; Sontenini 2009; Mehrpour 2014). Secondly, most studies examining speech and 
language outcomes for individuals receiving tPA have employed subjective scales and 
clinical ratings rather than using objective speech and language measures based on 
patient performance (Denier 2015; Kremer 2013; Maas 2012). Additionally, this study 
exercises a degree of methodological rigor not used in prior studies by examining speech 
and language recovery in patients who do and do not receive tPA meeting similar 
selection criteria. Finally, this study is clinically significant as it provides new 
information on how thrombolysis may impact the early spontaneous recovery phase after 
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a stroke. Increased knowledge in this area will help define the role of the speech language 
pathologist (SLP) early after the onset of a stroke and could potentially help guide the 
SLP in providing prognostic information for an individual with speech and language 
deficits.  
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Chapter Two- Literature Review 
 
Overview 
 
This chapter provides a review of current literature regarding stroke and tPA, 
supporting the need for this investigation.  Following a brief discussion about the impact 
of stroke, details about tissue plasminogen activator (tPA), its use, and its benefit will be 
shared. Next, information about aphasia after stroke and prognostic factors for aphasia 
will be presented. Finally, current literature on the impact of tPA on aphasia will be 
presented.  
 
Stroke 
According to the American Heart Association, someone in the world has a stroke 
approximately every 40 seconds (Benjamin et al, 2017). Some of these individuals will 
die but for many of those that survive, long-term disability may be their new reality. 
Medical and rehabilitative care can be costly and extensive, with individuals experiencing 
varied long-term deficits. Per person, the average cost, including both direct and indirect 
costs, of ischemic stroke care is estimated at around $140,000 over the course of a 
lifetime. This includes thousands of dollars in ongoing rehabilitative care and an average 
acute care hospital stay of 6 days, compared to 9.5 days in 1990 (Benjamin et al, 2017). 
Therefore, it is imperative to investigate the impact of various treatments on the 
rehabilitation of functional outcomes.  
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Thrombolysis Use 
 
 Since its FDA approval in 1996, tissue plasminogen activator (tPA) has been the 
treatment of choice for individuals with ischemic stroke to achieve thrombolysis. tPA is a 
protein, generally found on endothelial cells within blood vessels, that helps breakdown 
blood clots. It is a catalyst to convert plasminogen to plasmin, the enzyme that breaks 
down the clot (Klabunde, R., 2007). First produced by Genentech in 1982, the drug is 
manufactured by a recombinant DNA technique, so is often referred to as recombinant 
tPA (r-tPA). However, for the purposes of this paper, I will consistently use the 
abbreviation tPA. The drug can be administered either intravenously (IV) or intra-
arterially (IA). 
Early studies with tPA investigated dosing and safety of the drug, as well as the 
feasibility of completing early neurological assessments for tPA administration. Dosing 
of intravenous thrombolysis is generally determined based upon the weight of the person 
with stroke, calculated as milligrams per kilogram. A two-part series in 1992 examined 
both dosing and timing of administration. In part one, Brott and colleagues (1992) studied 
patients who received tPA within a 90-minute timeframe, receiving a range of doses from 
0.35-1.08 mg/kg. In part two of the same study, tPA was provided between 91-180 
minutes after stroke onset, with one of three doses: 0.6 mg/kg, 0.85 mg/kg, and 0.95 
mg/kg (Haley et al, 1992). While some methodological concerns are present in these 
studies, both found that the incidence of cerebral hemorrhage is significantly correlated to 
increasing dosage rates, with a maximum threshold of 0.85 mg/kg to limit the risk of 
hemorrhage. Both of these studies found 40-50% of individuals with a major neurological 
improvement by 24 hours, measured by use of the National Institute of Health Stroke 
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Scale (NIHSS). Delzoppo and colleagues (1992) also investigated a group of individuals 
with varying dosage rates of tPA, measured in million international units with a range of 
0.12-0.75 MIU/kg, and found no significant correlation between dosing and risk of 
hemorrhage. This may be attributed, however, to the lower dosage used in this study. 
Currently in standard practice, dosage is 0.9 mg/kg. 
 
Guidelines for Administration. Only certain individuals qualify to receive this 
drug upon admission to the hospital for a possible stroke. Reasons why an individual may 
not receive the treatment include time restrictions, medical contraindications, patient-
specific factors, and physician-specific factors.  
The biggest factor in tPA administration is time post onset. FDA approval 
currently recommends administration of IV tPA if a patient presents to the hospital within 
a three hour window of stroke symptom onset. Several early large-scale studies on tPA 
outcomes, known as NINDS (NINDS, 1995), ECASS I (Hacke et al, 1995), ECASS II 
(Hacke et al, 1998), ECASS III (Hacke et al, 2008), ATLANTIS A (Clark et al, 2000), 
and ATLANTIS B (Clark et al, 1999), provided initial information to develop current 
guidelines, including time of administration. Across these studies, authors investigated 
various windows of administration time between 3-6 hours, differing dosages of tPA, 
using outcome measures including the NIHSS, Barthel Index (BI), Modified Rankin 
Scale (mRS), and the Glasgow Outcome Scale, with contrasting results depending on 
time windows used (NINDS, 1995; Hacke et al, 1995; Hacke et al, 1998; Hacke et al, 
2008; Clark et al, 2000; Clark et al, 1999). A pooled analysis of these studies was 
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subsequently completed and support a favorable functional and survival outcome when 
tPA is given within 3-4.5 hours (Lees et al, 2010) of stroke onset. Although the FDA has 
not extended the recommended time for tPA, the American Heart Association has issued 
a set of guidelines and recommendations for administering tPA within 4.5 hours with 
specific exclusion criteria, including age greater than 80, use of oral anticoagulants, and 
an NIHSS of greater than 25 (Cheng & Kim, 2015). The European counterpart to the 
FDA has also extended its recommended window to 4.5 hours (Cheng & Kim 2015). 
Therefore, current general practice is administration within a 4.5 hour timeframe of 
stroke symptom onset.  
Although the window of possible administration has been extended to 4.5 hours, 
in practice, patients have better outcomes, including mortality and function, when they 
receive tPA more quickly (Prabhakaran, Ruff, & Berstein, 2015), supporting the idea that 
earlier reperfusion reduces the risk of death and leads to improved functional status. 
Ahmed and colleagues (2013) compared individuals receiving tPA within 3 hours, 
between 3-4.5 hours, and between 4.5-6 hours and found that functional independence 
was highest when the tPA was administered before 3 hours, while mortality was the same 
across all groups.  Similarly, Saver et al (2013) found earlier treatment with tPA to be 
associated with better outcomes, including improved ambulation, greater chance of 
discharge to home, reduced mortality, and reduced risk of adverse events such as 
intracranial hemorrhage. Delzoppo and colleagues (1992) also found that time to 
treatment was a significant predictor of outcomes and risk of hemorrhage. So while an 
individual may receive the treatment up to 4.5 hours after stroke onset, it is highly 
recommended to seek treatment as soon as possible.  
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Since the time window for administration is small, the decision not to seek care 
for the symptoms of a stroke immediately by some patients may limit their ability to 
receive this potentially lifesaving treatment. Individuals are less likely to get this 
intervention if they are older, arrive later at the hospital, or go to a smaller or non-
academic medical center (Fang et al, 2010; Hills & Johnston, 2006). In the area where the 
current study was completed, many individuals are excluded from receiving tPA because 
they did not seek medical attention quickly enough, an established issue in many areas 
(Eissa et al, 2013; Maze & Bakas, 2004).  
 There are also medical contraindications that may preclude tPA administration. 
Only individuals with an ischemic stroke, confirmed by CT scan, qualify to receive the 
drug, due to the risk of additional bleeding, worsening of neurological damage, and death 
with a hemorrhagic stroke. Even with ischemic stroke, the risk of hemorrhagic 
conversion of the stroke is of concern. Other medical factors initially thought to be 
contraindications include recent surgery or current use of blood thinning medications. 
However, more recently, these are of less concern for some physicians (Fraser, 2018) 
with more providing the intervention even in the presence of these established risk 
factors.  
Some also argue that tPA should not be given to individuals with a severe stroke. 
For example, guidelines from the AHA/ASA suggest administering the drug with caution 
to individuals with an NIHSS of 25 or higher. Supporting this, Davis et al (2008) point 
out that those with a large stroke will still have significant impairments, even after 
treatment with tPA, and the risk of hemorrhagic conversion and other complications seem 
to outweigh the benefits of the drug with this population. Similarly, in the ATLANTIS B 
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(Clark et al, 1999) trial, in those with NIHSS of greater than 20 and treated with tPA, 
there was a 100% mortality rate, highlighting the risk of administration in individuals 
who have a large stroke.  
Given the multitude of factors to consider in administration of tPA, neurologists 
are the bedside decision makers on whether the patient would benefit and should receive 
the treatment. Therefore, patient outcomes may be impacted by physician-specific 
factors, specifically physician bias. When a geographically limited group of neurologists 
were surveyed, they reported that the decision to use tPA was impacted by their own 
perception of quality of life after a stroke, as well as concern for the cost of 
implementation (Hovsepian & Karceski 2013; Shamy & Jaigobin, 2013). Additionally, 
uncertainty in interpreting neuroimaging results is a reported concern among physicians, 
impacting the decision to administer tPA (Shamy & Jaigobin, 2013). 
Age also appears to be a factor that impacts administration and guidelines suggest 
caution in patients over 80 years. In fact, in the AHA/ASA guidelines, this age threshold 
is a recommended exclusion criterion when providing tPA between 3-4.5 hours after 
stroke onset. However, in the International Stroke Trial-3 (IST-3 Collaborative Group, 
2012), authors found a significant benefit and limited risks to patients over this age 
threshold, concluding that age alone should not be a substantial factor in considering use 
of the treatment.  
Considering the multiple reasons that tPA is limited in administration, it is not 
surprising that its rate of usage is low. Although rates of administration of tPA have 
increased over the last 20 years, the drug is still underutilized. Fang, Cutler, and Rosen 
15 
  
(2010) reported usage rates less than 1% in 2001. In the first decade of this century, 
administration rates have reportedly varied between 2-8% for all persons admitted with 
stroke (Benjamin et al, 2017; Adeoye et al, 2011; Choi, Kang, Kang, Ko, & Bae, 2007; 
Fang et al, 2010; Hills & Johnston, 2006; Hoffmeister et al, 2013). Notably however, 
based on the 2015 “Get with the Guidelines” Stroke Quality reports from hospitals with 
established stroke centers, of the patients arriving at the hospital within two hours from 
symptom onset, 88% received tPA (Benjamin et al, 2017).  
 
Financial impact. In addition to potentially improved function, tPA appears to 
have financial benefits that impact the overall healthcare system. Patients receiving 
thrombolysis have shorter stays in the rehabilitation hospital and are more likely to 
discharge home, relieving some burden on long-term healthcare facilities (Meyer et al, 
2012). In general, the cost of rehabilitation is significantly lowered after a person receives 
tPA, with estimates that post-acute care rehabilitation costs are reduced by more than six 
million dollars per 1000 cases of tPA (Fagan, 2010). 
 
Risks of Use. Unfortunately, even though tPA is intended to improve functional 
outcomes, sometimes the opposite may occur. Cerebral hemorrhaging, with a subsequent 
decline in neurological functioning or even death, is a potential risk. Therefore, within the 
context of a patient’s clinical presentation, the risk of adverse events with tPA must be 
strongly considered in relation to the benefit of its use. Many research studies have 
16 
  
investigated specific adverse events with the use of tPA, including mortality rates and 
development of hemorrhage after intervention, and found varied results.  
The majority of the large studies (NINDS, 1995; Hacke et al, 1995; Hacke et al, 
1998; Hacke et al, 2008; Clark et al, 1999) previously mentioned found significantly 
more cerebral hemorrhages post tPA. A 2014 Cochrane review of 27 trials (Wardlaw, 
Murray, Berge, & del Zoppo), corroborates these results, concluding that patients 
receiving thrombolytic treatment had an increased risk of hemorrhage. This review also 
suggests evidence that patients have an increased risk of death and dependence when a 
hemorrhage occurs. Other studies support an increased risk of death after tPA. Clark and 
colleagues (2000), found significantly more deaths in those who received tPA. Similarly, 
the International Stroke Trial-3 (IST-3 Collaborative Group,  2012), a large randomized 
control trial administering tPA up to 6 hours post onset, found significantly more deaths 
in the treatment group within the first 7 days. 
Other studies do not consistently report increased risk of death after tPA, 
however. Many of the large randomized controlled trials (NINDS, 1995; Hacke et al, 
1995; Hacke et al, 1998; Hacke et al, 2008; Clark et al, 1999) found no significant 
difference in mortality between groups at three months. De Olivier & Damasceno (2011) 
reported that administration of tPA was not a significant factor in predicting survival with 
a population of individuals with stroke. Given the differing results in prior studies, the 
variability of risk of adverse events warrants the careful consideration by neurologists 
prior to administration of intravenous thrombolysis. 
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Functional Outcomes after Thrombolysis 
 
 A wealth of literature supports general functional benefits for individuals who get 
tPA. All of the aforementioned large-scale studies assessed functional change, often 
defined as “favorable outcomes”, based on global scales of function. In 1995, the NINDS 
study by the National Institute of Neurological Disorders and Stroke, using the NIHSS 
and mRS, revealed no significant difference between the tPA and non-tPA groups at 24 
hours. However, at three months, the tPA group was 30 percent more likely to have 
minimal or no disability, regardless of location of stroke lesion. In this study, almost half 
of the tPA group demonstrated a complete or near-complete recovery.  
 In the first ECASS study (Hacke et al, 1995), authors reported no significant 
difference in groups at three months when assessing with the BI or mRS. However, in the 
two follow-up ECASS studies, the results were very different. The second ECASS trial 
(Hacke et al, 1998) used the mRS as the primary outcome measure on 800 patients in a 
dichotomized fashion and found a significantly higher level of independence in the tPA 
group at three months. The final ECASS (Hacke et al, 2008) trial used the mRS and also 
created a global outcome score, which incorporated the mRS, BI, NIHSS, and the 
Glasgow Outcome Score. On both measures, with a study group of over 800 subjects, 
individuals who received tPA demonstrated significantly better outcomes at three 
months.  
In the first ATLANTIS trial (Clark et al, 2000), the primary outcome measure was 
a decrease of four or more points on the NIHSS, as well as use of the BI and mRS, to 
assess functional improvement. Interestingly, a significantly higher percentage of 
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individuals with tPA showed functional improvement at 24 hours but at day 30, the 
placebo group had better outcomes. On the follow up study, no significant difference in 
groups was observed at three months, when measuring functional outcomes as “excellent 
recovery”, defined as an NIHSS of 0 or 1. There were also no differences between groups 
at 30 or 90 days using the BI, mRS, and Glasgow Outcome Scale.  
Lees and colleagues (2010) reported findings from a study in which they pooled 
data from several large-scale studies in an attempt to compensate for various findings 
across studies. They found a more positive outcome as the onset time decreased and 
overall more benefits of the treatment when received within the 4.5 hour timeframe. 
When pooling the mRS scores, there was no difference between treated and untreated 
individuals when treatment was provided between 4.5-6 hours. However, within the 4.5 
hour timeframe the individuals who received tPA demonstrated better outcomes than 
those who did not. In the International Stroke Trial-3, the window of time was expanded 
to 6 hours and the outcomes included assessing for individuals who were “alive and 
independent” with a modified version of the mRS, the Oxford Handicap Score (OHS). 
Although there was no difference between those individuals who received tPA and those 
who did not at six months, the OHS scores were analyzed ordinally and there was a 
favorable shift for the group receiving tPA. Further analysis in this trial did indicate 
better outcomes if the tPA was administered within three hours, supporting early 
reperfusion. This supports previously discussed results by various other researchers 
(Ahmed et al, 2013; Prabhakaran et al, 2015; Saver et al, 2013). 
 In addition to the large-scale studies, other case and retrospective studies 
investigated the functional outcomes after tPA. In a single study report on a 98-year-old 
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individual with a left middle cerebral artery infarct of moderate severity, tPA resulted in 
complete resolution of symptoms per the NIHSS and complete recanalization of the M1 
branch of the artery within 2 hours (Neeb, 2013).  A retrospective study of 65 individuals 
with vertebrobasilar artery occlusion revealed those thrombolized had significantly more 
favorable functional results, based on subjectively created categories of severity (Hacke, 
Zeumer, Ferbert, Bruckmann, & del Zoppo, 1988). Another retrospective analysis of 
individuals with mild stroke, defined as an NIHSS of 6 or less, revealed that 87.2% of the 
population who received tPA were independent at three months (Nesi, Lucente, Nencini, 
Fancellu, & Inzitari, 2013). However, in this study an equal proportion of those with 
favorable and those with unfavorable outcomes received tPA, supporting other variables 
in recovery.  
 Several small prospectively completed studies also provide information about 
recovery of function after tPA, using NIHSS and mRS as outcome measures, both in the 
early recovery and long term timeframe, generally up to three months post onset. In a 
study in which very early dramatic recovery was defined as a drop of 10 points in the 
NIHSS by the end of the tPA infusion, Felberg et al (2002) found that 22% of the 
individuals with middle cerebral artery (MCA) infarcts receiving tPA had a dramatic 
recovery and a significantly higher percentage of this group achieved recanalization after 
infusion. Additionally, these people had significantly better mRS scores at long-term 
follow up. Two other studies found similar results. Kohrmann and colleagues (2008) 
investigated a group of patients that received tPA, finding a significant improvement 
from admission to 24 hour NIHSS, with also a large percentage (94%) of the population 
showing favorable outcomes at discharge. Kablau, Alonso, Hennerici, & Fatar, (2013) 
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also found that, in individuals with middle cerebral artery occlusion, those who received 
tPA exhibited significantly better NIHSS at one week and mRS upon long term follow up 
compared to those who did not receive tPA.  
 Some studies indicate that stroke survivors getting tPA have better functional 
outcomes when initial total scores on the NIHSS reflect a less severe stroke, if they are 
below the age of 85, and there is an absence of extensive MCA hyperdensity (Albers et 
al, 2000; Machmumpurath, Reddy, & Yan, 2012). Lower mean arterial BP at the time of 
onset has also been associated with positive functional outcomes (Albers et al, 2000; 
Machmumpurath et al, 2012) whereas the presence of aphasia has been found to 
negatively impact overall recovery after stroke, even in those treated with tPA (Nesi, 
2012). 
Research also suggests there may be a relationship between severity of stroke, 
timing of tPA administration, and functional outcomes. Strbian and colleagues (2013) 
reported that thrombolysis within 90 minutes resulted in better overall outcomes for 
individuals with moderate stroke, defined as a score between 7-12 on the NIHSS, 
compared to those with mild or severe stroke, defined as scores of 0-6 or 12 and higher 
on the NIHSS, respectively. Similary, Nesi and colleagues (2012) found that in 
individuals with mild stroke, tPA did not have a significant impact on favorable 
outcomes. In contrast, Kohrmann et al (2009) argues for use of tPA in individuals with 
mild CVA due to findings of significant improvement after treatment. With the varied 
evidence, tPA is considered more cautiously if the stroke is rated as ‘mild’ or ‘severe’, 
based on the NIHSS score.  
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Thus far, the literature reviewed with respect to the impact of tPA on functional 
outcomes after ischemic strokes indicates that individuals that receive tPA experience 
better outcomes providing certain guidelines, such as time of administration, are adhered 
to. It is also important to point out that the functional outcomes associated with tPA use 
or its lack of use have only been measured in a general sense with three scales, the 
NIHSS, Barthel Index, and Modified Rankin Stroke Scale. While these indices provide 
valuable information relative to basic functions (walking, toileting, eating, and self-care 
and others) that might be affected by stroke, they do not address changes, for better or 
worse, in higher level functions such as speech, language, cognition, memory, or 
executive functions. Minor impairments in these critical areas can be disrupting in a 
major way in stroke patients in the absence of physical restrictions (Numminen et al., 
2016). In addition, most of the studies examining the effects of tPA have assessed 
outcomes very early, within hours of tPA infusion, or much later, three months of longer 
after stroke onset.   
The next part of this chapter will discuss aphasia after stroke and then current 
literature regarding tPA and its impact on early speech and language recovery. 
 
Aphasia after Stroke  
 
Aphasia was defined in Chapter 1 as a multi-modal language disorder resulting 
from damage to the brain’s language dominant hemisphere. An estimated 15-30% of 
individuals that suffer strokes present with symptoms of aphasia at the time of admission 
to the hospital (Engleter et al, 2006; Inatomi et al, 2008; Laska et al, 2001; Lazar et al, 
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2010; Maas et al 2012). These symptoms can range from minor word-finding difficulties 
to near-complete destruction of rule-based semantic, syntactic, and phonological domains 
of language resulting in Global aphasia. For a small number of stroke patients with 
aphasia, the symptoms of aphasia disappear within a few hours. For others, aphasic 
deficits resolve during the spontaneous recovery period (in the first month post-onset) as 
a result of healing of the damaged brain. But for most patients, the language deficits 
associated with aphasia persist throughout the acute, subacute, and chronic phases of 
stroke recovery, and the person’s life. (Bakheit et al, 2007; Bersano et al, 2009; Laska et 
al 2010). Fortunately, aphasia has an improving course. People with aphasia improve 
their speech and language functioning over time. These improvements are felt to result 
from several factors according to many neurobehavioral scientists. A summary of the 
factors considered to impact improvements in speech and language functioning in 
persons with aphasia follows.  
Initial severity of aphasia has repeatedly been shown to be one of the strongest 
predictors of both short- and long-term language outcomes (Bersano et al, 2009; Chapey, 
2008; Kertesz and McCabe, 1977; Hojo et al, 1985; Sarno and Levita, 1979; Plowman, 
Hentz and Ellis, 2012). This can only be determined after the patient has become 
neurologically stable and the life-threatening consequences of stroke have been dealt with 
by the medical team (Brookshire, 2015).  In general, for patients with aphasia who are 
considered to be neurologically stable, individuals with more severe language deficits at 
stroke onset have poorer outcomes compared to those with milder impairments. Severity 
of aphasia and speech and language improvement in patients with aphasia has also been 
found to be influenced by the site and extent of the causative lesion or lesions caused by 
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the stroke (Kertesz, 1979; Kertesz & McCabe, 1977; Knopman, Selnes, Nccum & 
Associats, 1984, 1985; Rubens, 1977) as well as the extent to which the brain damage 
that causes aphasia disrupts connections between areas of the brain’s left hemisphere 
important to language processing  (Hillis et al, 2000; Kertesz, 1979).  
The role of age on speech and language outcomes for stroke patients with aphasia 
appears to be equivocal. Some researchers have found older patients have poorer 
language outcomes (Chapey, 2008; Ogrezeanu et al, 1994) while others report no 
relationship between age and improvement in language functioning in aphasia (Basso, 
1992; de Riesthal and Wertz, 2004). However, individuals with advanced age, 
specifically over 65, have a higher chance of institutionalization after stroke (Edwardson 
& Dromerick, 2017; Koennecke et al, 2011; Konig et al, 2008; McClung, Gonzalez 
Rothi, & Nadeau, 2010; Plowman et al, 2012; Ross & Wertz, 2001), which would 
negatively impact opportunities for communication and potentially impact language 
improvement. 
 Other demographic factors should be mentioned relative to their impact or lack of 
impact on aphasia outcomes. Gender has been found to be equivocal as a significant 
predictive factor for aphasia recovery with some authors concluding that females have 
poorer outcomes (Holland, Greenhouse, Fromm, & Swindoll, 1989) and others finding 
males with poorer outcomes (Sarno & Levita, 1979). Similarly, while many have studied 
it, the impact of level of education on general stroke outcomes is inconclusive (Connor et 
al, 2001; Lazar et al, 2008; Ross & Wertz, 2001; Smith, 1971; Benjamin et al, 2017). 
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Patient complexity is often determined by the presence of concurrent medical 
problems, or co-morbidities. Individuals with fewer co-morbidities along with their 
aphasia have shorter lengths of stay and better recovery (Holland et al, 1989; Marshall & 
Phillips, 1985). Another indicator of patient complexity is the need for polypharmacy, 
defined as more than five medications. Certain medications can even have a negative 
impact on functional recovery (Goldstein, 1995; Goldstein, 1998) after stroke. Therefore, 
polypharmacy at the time of stroke and during recovery may be a contributing factor to 
the success of aphasia rehabilitation.  
 
Speech and Language Improvement after tPA 
 
 As evinced in the material that has been reviewed so far, a myriad of factors 
influences overall recovery of speech and language skills after left hemisphere stroke. 
Early recovery, however, within the acute phase, is often driven by spontaneous recovery, 
associated with improvements in language skills by patients with aphasia without 
therapeutic intervention. These improvements result from reduced swelling, increased 
blood flow, resolution of psychological shock, and lessening of diaschesis associated 
with healing of the brain (Kertesz & McCabe, 1977; Rubens, 1977; Wepman, 1972). Two 
phases of spontaneous recovery have been recognized, early and late. The early phase 
begins as soon as the 2nd or 3rd day post onset (Rubens, 1977) and continues for 
approximately 2 weeks (Pashek & Holland, 1988; Pederson, Jorgensen, Nakayama, 
Raaschou, & Olson, 1995). Consequently, within the first several days post ictus, patients 
with aphasia are highly variable. Daily fluctuation makes accurate assessment difficult. 
Tissue reperfusion within the early days post stroke can also be influenced by completed 
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procedures such as carotid endarterectomy and stenting, induced blood pressure changes, 
and other methods of spontaneous reperfusion (Hillis & Heidler, 2002). In the first week, 
with non-thromoblized patients, location of infarct, age, and maintenance of blood 
pressure are also significant factors in early aphasia recovery (Muscari et al, 2013).   
There is consensus that these changes start early and the majority of spontaneous 
recovery continues for several weeks after the insult (Culton, 1969; El Hachioui et al, 
2012; Hillis and Heidler, 2002; Pederson et al, 1995). Persons with aphasia can have 
significant gains within the first few months, even in the absence of ongoing speech and 
language therapy (Culton, 1969; Hartman, 1981). One of the more informative studies on 
spontaneous recovery was completed by Pederson and colleagues in 1995, in which 
investigators completed weekly assessments on 330 persons with aphasia and found 84% 
and 95% of the sample exhibited stationary language improvement at two and six weeks 
post onset, respectively. This is a substantial gain, especially considering no therapy to 
address impairments. El Hachioui (2012) found similar patterns of early recovery across 
a sample of 147 persons with aphasia at weekly intervals, irrespective of whether they 
received any aphasia therapy, suggesting considerable reliance on the process of 
spontaneous recovery. However, the impact of tPA on speech and language skills during 
this spontaneous recovery phase is not definitively provided in the current literature.  
Research specifically addressing recovery of speech and language deficits after 
thrombolysis consists of case studies, retrospective analyses, and studies using subjective 
rating scales as outcome measures. Few prospective, group studies provide evidence of 
the impact of tPA on specific speech and language tasks. Several case studies report 
significant improvement of language deficits in individuals of varying age and severity, 
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even full recovery at times (Cho, Hermier, & Nighoghossian, 2015; Mazza, 2012; 
Mehrpour, Motamed, Aghaei, Jalali, & Ghoreishi, 2014; Sontineni, Mooss, Andukuri, 
Schima, & Esterbrooks, 2009). One of the only investigations using a standardized speech 
and language measure was a case series by Finch et al in 2014, in which four individuals 
who received tPA were measured at two weeks and again at three months with the 
Western Aphasia Battery (WAB) and a Motor Assessment Scale. In these cases, authors 
were unable to detect any reliable change in language function related to the tPA.  
 Restrospective group studies, the majority of which use the NIHSS to measure 
speech and language changes, overall suggest good recovery of deficits with 
administration of tPA. One retrospective study investigated only individuals who had 
aphasia present and compared the NIHSS and mRS scores at the end of an inpatient 
rehabilitation program for those who did and did not receive tPA. With 37 individuals in 
each group, the tPA group scored significantly higher at the end of a rehabilitation 
program on these scales compared to their counterparts who did not receive tPA (Meiner 
et al, 2010), with authors concluding that tPA has a significant impact on speech and 
language recovery. Another study looked specifically at a group of more than 600 
individuals with isolated aphasia as defined by the aphasia subscale of the NIHSS, all of 
whom received tPA (Lundstrom, Zini, Wahlgren, & Ahmed, 2015). This study 
retrospectively analyzed the NIHSS scores at seven days and the mRS scores at three 
months, finding that almost half of the population resolved by one week and the vast 
majority (86%) were functionally independent by three months. Therefore, authors report 
that persons with isolated aphasia, in the absence of other physical impairments, may 
respond more readily to medical treatments, such as tPA.  
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In one of the few retrospective group studies using a standardized aphasia 
assessment, Jacquin and colleagues (2014) considered Boston Diagnostic Aphasia 
Examination (BDAE) scores at one week and three months after stroke to compare one 
cohort of subjects who received tPA to one group that did not. Authors reports 
improvement in speech and language after tPA because a significant difference was 
observed in scores between the thrombolyzed individuals and the non-thrombolyzed 
individuals at both time points.  
One additional retrospective study used the BDAE scores, in addition to the 
Lisbon Aphasia Assessment Battery and a created Composite Verbal Score (CVS), 
including subscale scores on the NIHSS (Martins et al, 2017). This analysis included only 
individuals with a left MCA infarct who received tPA. Results indicated that 31% of 
individuals with aphasia had complete recovery and 72% had some recovery after tPA on 
day seven (Martins et al, 2017). Authors also found significant correlation between the 
CVS and the standardized measures in this study, suggesting that use of this novel scale 
can be used to predict improvement on objective tasks.   
 Prospective studies specifically investigating early speech and language deficits 
after tPA are limited and have used the NIHSS and other subjective scales as a primary 
outcome measure. In 2012, Maas and colleagues used the NIHSS to investigate changes 
in those with aphasia starting in the ‘hyperacute’ window, defined as 12 hours after 
stroke. The aim of the study was to examine the prognosis of aphasia in a group of 204 
individuals, 60 of whom received tPA. Of the 60, authors found that from baseline to six 
months 86% improved, defined as any decrease in language score on the NIHSS and 73% 
resolved symptoms, defined as a language score of zero on the NIHSS. Investigators in 
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this study concluded that tPA is an effective treatment to significantly improve speech 
and language skills.  
Another study used similar guidelines to define ‘improvement’ based upon 
changes in the NIHSS language score (Kremer, Perren, Kappelin, Selariu, Abul-Kasim, 
2013). In 50 individuals with aphasia who received tPA, authors found that 16% of the 
group improved in their aphasia score at 24 hours after stroke onset; however, this was 
not a statistically significant finding. At 24 hours, 46% of the population demonstrated 
global improvements. Authors also found a significant correlation between infarct 
volume on CT scan and aphasia score, suggesting size of lesion as a significant factor in 
functional impairment. Additionally, the difference in individuals with improved aphasia 
at three months was not significant in this study.  
A recent prospective study (Denier et al, 2015) used the NIHSS to measure 
change in the first week after stroke. All participants in this study received thrombolysis 
and authors created two measures using the NIHSS subscales: a composite language 
score and a composite motor score. Of the 338 individuals who received tPA, 137 had 
aphasia. The NIHSS was used to record aphasia scores at baseline, 24 hours, and day 
seven. The individuals with aphasia in this study also received daily speech and language 
therapy if appropriate. Of these, 10% demonstrated what the authors called a ‘dramatic 
recovery’. The individuals with aphasia and no associated limb deficits who received tPA 
had significantly better aphasia outcomes compared to those with limb deficits. Further 
analysis of this data set (Denier, 2016) analyzed individuals with isolated aphasia and 
showed that compared to those who did not receive tPA, the individuals who did 
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performed significantly better on the NIHSS, composite language score, and the LAST 
screening at one week after stroke.  
In summary, current literature suggests improvement of speech and language 
skills when tPA is used as a treatment after stroke. However, data are variable and 
suggest that improvement may not happen in the early post onset period. Research also 
indicates that individuals with isolated aphasia may respond more readily to tPA 
treatment compared to those with strokes characterized by more comprehensive deficits. 
Measures used thus far in studies have primarily been subjective scales, which may not 
provide a comprehensive picture of impairment or specific changes in skills (Finch, 
Hayward, Fleming, & Copland, 2013).  
This study aims to address continued questions about the response of speech and 
language skills to the use of thrombolysis and the lack of prospective studies using 
specific speech and language tasks, especially during the spontaneous recovery phase. 
The goal is to gather more descriptive and prognostic information about what early 
speech and language recovery looks like for those individuals who do and do not receive 
this neuro-protective intervention. Our patients are changing significantly during the time 
required for the SLP to make decisions about prognosis and rehabilitation needs. It is 
imperative for acute care SLPs to have more data on the progression and prognosis of 
individuals with aphasia after a stroke, with and without other medical interventions, to 
help inform best practice, patient education, and resource management within the 
hospital.  
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Chapter Three- Methodology 
 
Purpose 
 
The purpose of this study was to examine early speech and language changes in 
survivors of a first-ever stroke with aphasia who did and did not receive tPA. To do this, 
a prospective observational design was utilized. The study was approved by the 
University of Kentucky Office of Research Integrity and Institutional Review Board 
(Protocol # 15-0066-P1H). 
 
Participant Recruitment 
 
To participate in the study, subjects were required to meet the following inclusion 
criteria: 1) diagnosis of a unilateral left hemisphere ischemic stroke with aphasia, 2) right 
handed, 3) no prior strokes, 4) age minimum of 18 years old, 5) no other neurological 
diagnoses that may have resulted in speech and language impairments, and 6) Native 
English speaker. No upper age limit was utilized.  
 Between April 2015 and October 2017, a total of 627 patients admitted with a 
diagnosis of stroke to the University of Kentucky Medical Center were screened for 
possible inclusion in the study. Screening was completed by the primary investigator or a 
trained research assistant. This was a convenience sample, as the investigator had direct 
clinical access to these patients and was a member of the stroke assessment team. 
However, not all consecutive stroke admissions were able to be screened due to 
limitations in the investigator’s schedule. Of the 627 potential participants screened, 432 
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had a left hemisphere ischemic stroke. Figure 3.1 shows that of this number, 32 patients 
were originally considered to have met inclusion criteria.  All of these individuals were 
asked to give informed consent for participation within the first 24 hours after their 
stroke. If the primary investigator determined a subject to have impaired consent 
capacity, as approved by the IRB, consent was obtained from a Legally Authorized 
Representative (LAR). Four of the 32 subjects meeting selection criterion did not 
participate in the study; two of the individuals thought to have met inclusion criteria were 
found not to have had strokes and were eventually ruled out; two subjects refused to 
participate. Of the remaining 26 subjects who gave consent, 13 received tPA and 13 did 
not. The administration of tPA was solely the decision of the admitting neurologist(s) and 
made before the participant gave consent to participate in the study. Table 3.1 provides 
background, demographic, and medical information on each participant who did and did 
not receive tPA. For the entire sample, the mean age was 70.7 years (Standard deviation: 
13.3; Range: 46-93). The National Institute of Health Stroke Scale (NIHSS), as a measure 
of stroke severity, was available on each participant both upon admission and at twenty-
four hours after stroke. The mean NIHSS total score at time of admission for the group 
was 10.8 (Standard deviation: 5.9; Range: 1-20). 
 
Procedures/Measures 
 
After informed consent was obtained, each subject was briefly interviewed by the 
primary investigator to establish rapport and was administered simple vision and hearing 
screening tests to ensure validity of data collection. When a participant could not respond 
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verbally, hearing was screened using an oto-acoustic emission (OAE) device, requiring 
no direct response from the participant. If the participant was verbal, hearing was 
screened using the CID Everyday Speech Sentences (Davis and Silverman, 1978). Vision 
was screened with a modified version of a word scanning/cancellation task (Beukelman 
& Mirenda, 1998). See Appendices A and B for hearing and vision screening tools. 
Participants were scheduled to be assessed four times during the course of the 
study with four objective tasks (1) forward digit repetition (FDR), (2) polysyllabic word 
repetition (PWR), (3) picture description (PD), and (4) picture naming (PN). These tasks 
were selected because they are commonly used by speech language pathologists to assess 
speech and language abilities of individuals with aphasia in acute hospital settings, 
contain few materials, are convenient to use in clinical environments, contain relatively 
straight-forward instructions, and are easily recorded by audiotape for later scoring and 
analysis. These tasks are briefly described in the following paragraphs. Details on the 
materials, instructions, administration, and scoring of each task are provided in 
Appendices C, D, E and F. 
Forward Digit Repetition (FDR): The FDR task was used to assess the 
participant’s short term and working memory skills. This task required the subject to 
repeat five sets of 5, 6, and 7-digit strings after the examiner. The subject was credited for 
digit produced in the correct location of the digit string.  
Polysyllabic Word Repetition (PWR): For the PWR task, the subject repeated 10 
polysyllabic words one-at-a-time after the examiner from a protocol developed by 
Rosenbek and colleagues (Rosenbek, Wertz, & LaPointe, 1989). This task was used to 
33 
  
confirm the presence and severity of apraxia of speech, a neuromotor speech disorder 
often co-occurring with aphasia (Wambaugh & Shuster, 2008).  
Picture Description (PD): Two pictures, the “Picnic Scene” from the revised 
Western Aphasia Battery-Revised (WAB-R; Kertesz, 2006) and the “Cookie Theft” 
picture from the Boston Diagnostic Aphasia Examination-3 (BDAE-3; Goodglass, 
Kaplan, & Barresi, 2000) were used to obtain a connected speech sample from each 
subject. Both tasks have been used successfully in several studies to assess connected 
speech abilities of persons with aphasia and have high reliability and good validity 
(Golper, Thorpe, Tompkins, Marshall, & Rau, 1980; Nicholas & Brookshire, 1995; 
Yorkston & Beukelman, 1981). These discourse samples were used to calculate correct 
information units and words per minute. Correct information units provide a measure of 
word retrieval in discourse, specifically assessing informativeness and efficiency of 
communication. Words per minute provide a measure of verbal fluency and rate of 
speech.  
Confrontational Picture Naming (PN): Stimuli from the short forms of the 
Philadelphia Naming Test (PNT: Walker & Schwartz, 2012) were used to develop four 
separate 10-item picture naming tasks. Pictures for each task were selected so as to 
adhere to the word frequency distributional properties of the original PNT. Pictures were 
presented for naming one-by-one without cues or prompts.  
Table 3.2 shows the location where assessments took place for each participant 
within 24 hours of stroke onset, 1 week, 2 weeks, and 3 months post-onset. The 24 hour 
assessment was conducted in the acute care hospital for all participants. Subsequent 
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assessments took place in either the acute care hospital, rehabilitation hospital, or 
participant’s home depending on where the participant was located at that assessment. 
The four objective tasks were administered to participants in the same order-FDR, PWR, 
PD, and PN- at the four assessments. The primary investigator was responsible for all 
evaluations, which lasted approximately 20 minutes and were completed in a quiet, well-
lit environment. To ensure consistency by the primary investigator across assessments, a 
script for data collection was utilized. See Appendix G for script/procedures. To limit 
frustration from the participant, no prompting or cues were provided during data 
collection. Since all assessment tasks required verbal responses and the examiner’s 
scoring of responses would lengthen testing time, subjects’ responses were audiotaped 
and scored at a later time. In addition, out of consideration of the fact that participants 
were in acute stages receiving intensive medical care, precautions were taken to terminate 
administration of a dependent measures if the subject became frustrated, failed 
repeatedly, or could not perform a task (See Appendices). An additional measure, the 
Stroke and Aphasia Quality of Life Scale-39 was also included as part of the 3 month 
post-onset assessment.  
Stroke and Aphasia Quality of Life-39 (SAQOL-39): This self-assessment scale 
was  scheduled to be administered only at the three-month assessment because it was 
anticipated subjects would no longer be in a hospital at this time and earlier assessments 
took place too early to provide self-reports on quality of life after stroke. The SAQOL-39 
measures health-related quality of life in four sub-domains after stroke: physical, 
psychosocial, communication, and energy. The scale has been found to demonstrate good 
acceptability, internal consistency, test-retest reliability, and construct validity (Hilari, 
35 
  
Byng, Lamping, & Smith, 2003). These psychometric properties also apply when the 
SAQOL-39 is administered by proxy and via telephone (Hilari, Owen, & Farrelly, 2007; 
Caute, Northcott, Clarkson, Pring, & Hilari, 2012). See Appendix H for a copy of the 
SAQOL-39. When possible, the SAQOL-39 was given directly to the person with 
aphasia. However, in some cases, the measure was completed by proxy to a close family 
member who lived with the participant. The overall score and the scores for each domain 
were calculated. In analysis, the overall score, communication score, and psychosocial 
score were used.  
 
Demographic, Medical, and Speech-Language Therapy Data 
Demographic, medical, and speech and language data were obtained for each 
participant. Most of these data were obtained at the start of the study and entered on the 
data collection forms shown in Appendices I.1-4. Much of the demographic and medical 
information was obtained from the medical record, patient, or family report. This 
included contact information, date of birth, level of education, location of stroke in the 
brain, tPA administration information, medications, co-morbidities, ambulation status, 
and ongoing National Institute of Health Stroke Scale (NIHSS) scores assigned by 
medical personnel. After informed consent was given, this information was entered on 
the data collection forms. 
Demographic information included the subject’s age (in years), gender (male or 
female), and highest level of education (elementary school, middle school, high school, 
technical school, bachelor’s degree, and post-bachelor’s degree). Medical data included 
the subject’s overall and language scores on the National Institute of Health Stroke Scale 
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(NIHSS), weighted score on the Charleston Comorbidity Index (CCI; deGroot, 
Beckerman, Lankhorst, & Bouter, 2001), and a polypharmacy designation of “plus” or 
“minus” based on the number of medications the individual was taking.  
The National Institute of Health Stroke Scale (NIHSS) is a clinical tool used by 
many neurologists and stroke unit nurses to measure level of impairment after a stroke 
and to document changes in stroke severity in the short- and long-term. The NIHSS has 
11 items, including the following domains: level of consciousness, gaze, visual, facial 
palsy, motor arm, motor leg, limb ataxia, sensory, language, dysarthria, and neglect. Each 
item has a graded scoring system of 0-3 or 0-4, with a total summed score varying from 
0-42; a higher score reflects a more severe impairment. See Appendix K for a copy of the 
NIHSS. In this study, the NIHSS was scored by physicians and nurses as part of standard 
stroke unit care. Both the total and language scores were recorded by the investigator 
from the medical record. To maintain consistency across participants, admission scores 
were recorded from the history and physical document, which was completed by the 
physician. The 24 hour NIHSS scores, however, were not always scored by the physician 
and were therefore recorded from the nursing flowsheets.  
Comorbidities (associated health problems) provide an indication of the 
individual’s pre-stroke health status, which may impact overall recovery. For this study, 
this was determined using the Charlson Comorbidity Index (CCI). The CCI index was 
originally validated on a large study population that included patients with stroke 
(deGroot, Beckerman, Lankhorst, & Bouter, 2001) and has been used in stroke outcome 
studies (Goldstein, Samsa, Matchar, & Horner, 2004). A patient’s score on the CCI 
represents a sum of assigned weights for specific diagnoses. See Appendix J for a list of 
37 
  
included diagnoses and weights. CCI scores for each participant in this study were 
determined from a review of diagnoses listed in the note when the patient was admitted to 
the acute care hospital.  
Another measure of patient complexity is the number of medications prescribed. 
To determine the risk of polypharmacy for each participant, a simple count of the number 
of medications ordered during hospitalization was made. The median number of 
medications taken by study participants was 10.  Therefore, participants who had more 
than 10 medications were coded as positive (+) for polypharmacy and those with fewer 
were coded as negative (-) for polypharmacy.  
For those participants completing the three-month assessment, the amount of 
speech and language intervention was calculated based on number of hours of therapy. 
By the time of their third assessment (2 weeks) most of the participants had been sent 
home, to a rehabilitation hospital, or to a long term care facility. Between the time of the 
2 week and 3 month assessments, most participants received varying amounts of formal 
speech and language therapy. Since the amount of speech and language therapy a patient 
with aphasia receives influences recovery, the total number of formal speech and 
language hours was calculated for each patient from 24 hours to 3 months. 
  
Reliability and Validity 
 
Several steps were taken to minimize bias. All dependent measures were given by 
the primary investigator using a script to ensure consistent presentation of instructions. 
Subjects’ responses to each task were audio recorded and then scored by an independent 
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listener. For the FDR, PWR, and PD, a trained research assistant completed all scoring. 
To calculate information units (IUs), both the research assistant and investigator 
completed extensive training and were required to demonstrate competency in calculating 
IUs prior to data scoring. Inter-rater reliability testing was completed on 10% of 
participant responses for each outcome measure.   
 
Data Analysis 
 
Data for analyses were entered in an Excel database and imported into Statistical 
Package for the Social Sciences (SPSS). All statistical analyses were performed using 
SPSS v18. Independent two-sample t tests were used for group comparisons on 
demographic and medical variable measures. Repeated measures multivariate analysis of 
variance (MANOVA) was used to analyze the within- and between- subjects effects of 
time and group on mean scores on the speech and language measures. Independent two-
sample t tests were used post hoc to investigate individual differences between tPA/non-
tPA group means. All measures were tested for normality with Shapiro-Wilks tests. Data 
sets were observed to be normally distributed and parametric tests were used. Finally, 
correlational analyses and linear regression analysis were completed to investigate 
relationships between dependent measures and other variables. In agreement with the 
sample size analysis completed a priori, an alpha of 0.1 was chosen to detect significance.  
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Figure 3. 1: Study Recruitment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Right Hemisphere/Bilateral 
Lesions/Brainstem Stroke 
195 
Recruited for study 
32 
Declined 
4 
 
2 recruited but ended up 
with no CVA 
Completed Data 
Collection 
26 
Total number of patients 
screened 
627 
Total Left Hemisphere Stroke 
432 
Did not meet inclusion criteria: 
Prior CVA     214 
Prior Neurological Dx     23 
Left Handed     6 
Thrombectomy       5 
No Speech/Lang deficits     154 
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Table 3. 1 
Demographic and medical variables on participants who received tPA (n=13) 
Sub Age Gender Education Lesion Location CCI
* 
Polypharmacy 
(+/-) 
NIHSS Total 
Admission 
1 81 Male High School Left MCA 0 - 4 
2 93 Female High school Left M1 branch 0 - 14 
3 69 Male Technical School Left frontal lobe 0 - 10 
4 53 Male College Left insular cortex 0 + 20 
5 83 Female Technical School Left thalamus, BG 1 - 7 
6 66 Male Middle School Left MCA 0 - 13 
7 61 Male College Left MCA 0 - 18 
8 74 Male High school  Left frontoparietal 2 - 6 
9 46 Male High school Left temporal 
lobe, BG 
0 -  
15 
10 67 Female High school Left parietal lobe 1 + 18 
11 85 Male Unknown Left MCA 3 + 16 
12 77 Male High school Left MCA 0 + 7 
13 49 Male High school Left MCA 0 - 12 
*Charlson Comorbidity Index 
 
 
Demographic and medical variables on participants who did not receive tPA (n=13) 
Subject Age Gender Education Lesion Location CCI
* 
Polypharmacy 
(+/-) 
NIHSS Total 
Admission 
1 81 Male Middle School Left thalamus 1 + 14 
2 63 Female Middle School Left frontal lobe 1 + 5 
3 
59 Female College 
Left internal 
capsule 3 + 2 
4 60 Female College Left MCA 0 - 15 
5 
85 Female 
Elementary 
School 
Left occipital lobe 0 - 12 
6 
82 Female High school 
Left temporal and 
parietal lobes 0 - 4 
7 77 Male Post graduate Left MCA 0 - 8 
8 
86 Male 
Elementary 
School 
Left MCA 5 - 18 
9 57 Female College Left parietal 1 - 6 
10 64 Male Middle School Left MCA 0 + 13 
11 74 Female College Left MCA 0 + 1 
12 56 Male High school Left MCA 3 + 20 
13 90 Female High school Left MCA 0 + 3 
*Charlson Comorbidity Index 
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Table 3. 2 
Assessment locations for individuals who received tPA (n=13)  
 
PARTICIPANT 24 HOUR  
ASSESSMENT 
1 WEEK  
ASSESSMENT 
2 WEEK  
ASSESSMENT 
3 MONTH 
ASSESSMENT 
1 ACH ACH RH NA 
2 ACH ACH ACH H 
3 ACH ACH RH NA 
4 ACH H H H 
5 ACH H H NA 
6 ACH ACH ACH NA 
7 ACH ACH RH H 
8 ACH H H H 
9 ACH OP OP H 
10 ACH ACH ACH NA 
11 ACH ACH ACH NA 
12 ACH H H H 
13 ACH OP OP NA 
ACH- Acute Care Hospital; RH- Rehabilitation Hospital; OP- Outpatient Clinic; H- Participant’s 
Home; NA- Assessment not completed 
 
 
 
Assessment locations for individuals who did not receive tPA (n=13) 
 
 
PARTICIPANT 24 HOUR 
ASSESSMENT 
1 WEEK  
ASSESSMENT 
2 WEEK 
ASSESSMENT 
3 MONTH 
ASSESSMENT 
1 ACH ACH RH NA 
2 ACH H H H 
3 ACH H H NA 
4 ACH ACH RH OP 
5 ACH ACH RH NA 
6 ACH ACH RH NA 
7 ACH ACH RH NA 
8 ACH ACH ACH NA 
9 ACH H H NA 
10 ACH ACH RH NA 
11 ACH ACH H H 
12 ACH ACH RH H 
13 ACH H H H 
ACH- Acute Care Hospital; RH- Rehabilitation Hospital; OP- Outpatient Clinic; H- Participant’s 
Home; NA- Assessment not complete 
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Chapter 4- Results 
 
This chapter begins with a summary of the analyses carried out to determine the 
appropriate sample size for the study followed by a brief description of the methods used 
to determine inter-rater reliability in scoring. This is followed by a set of analyses 
designed to answer the primary research questions posed for the study, investigating 
changes in speech and language in the acute phase of stroke recovery. The final segment 
in this chapter explains results of the secondary research question, investigating the 
relationship between performance on speech, language, and quality of life measure, and 
various demographic, medical, and therapeutic variables.  
 
Sample Size Analysis 
 
To assess for an adequate sample size, an a priori analysis was completed using 
one of the outcome measures for the study, percent correct information units. This 
outcome measure was chosen because it provides an overall picture of a participant’s 
word retrieval in connected speech. Based on pilot data (Boyle, 2014; Gordon, 2008), the 
investigator expected the mean percentage of correct information units in a language 
sample to be 0.5 (50%) for participants after a left hemisphere stroke not receiving tPA, 
with a standard deviation of 0.15 (15%).  Further, the mean percentage was estimated to 
be 0.65 in subjects receiving tPA.  Using a two-sided test with a 0.1 significance level, 
due to the pilot nature of this trial, a minimum of 13 participants per trial arm were 
required to have 80% power to detect this difference in the means.   
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Scoring Reliability 
 
 To ensure accuracy in scoring responses, inter-scorer reliability was calculated for 
each outcome measure. Ten percent of responses at each assessment were randomly 
selected for reliability checking. For FDR, %IUs, and WPM, responses were scored by a 
trained research assistant and re-scored by the primary investigator. For PWR, scoring 
was completed by the primary investigator and re-scored by an independent SLP. For the 
PN task, scoring was completed by an independent SLP and re-scored by the primary 
investigator. Inter-rater reliability was calculated using the following formula: [the total 
number of agreements/ the total number of possible agreements] x 100. An a priori level 
of 90% agreement was deemed adequate for the study. Reliability testing revealed 
agreement of 100% for FDR, 91% for PWR, 91.6% for %IUs, 91.6% for WPM, and 98% 
for PN. 
 
Research Questions 
 
Primary Questions 
 
 The three primary questions in this study investigate the differences in speech and 
language recovery and quality of life over various assessment points in individuals after 
first-ever left hemisphere stroke. The first question investigates the recovery of the entire 
sample of individuals, regardless of whether they received neuroprotective intervention 
during a two-week timeframe, with assessments at 24 hours, 1 week, and 2 weeks post 
stroke. The second question evaluates the differences between two groups- those who 
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received tPA and those who did not- at the same assessment points. The third question 
assesses the differences on speech and language tasks and a quality of life measure at 
three months between those who received tPA and those who did not, all of whom had 
received some speech and language therapy at the three month assessment.  
Question 1: Do persons with aphasia following a first-ever left hemisphere 
ischemic stroke improve speech and language skills in the first two weeks post onset? 
Table 4.1 gives the means and standard deviations for the Forward Digit 
Repetition (FDR), Polysyllabic Word Repetition (PWR), Picture Naming (PN), and the 
two measures associated with Picture Description, percent information units (%IU), and 
words per minute (WPM) for the 24 hour, 1 week, and 2 week assessments. These data 
pertain to all 26 subjects irrespective of tPA status and hence provide an indication of 
language changes in the acute phase of stroke recovery.  To address research question 1, 
a repeated measures multivariate analysis of variance (MANOVA) was carried out for 
each of the aforementioned outcome measures to examine differences in scores over 
time. Table 4.1 shows that statistically significant gains were evinced on all of the 
language tasks examined over the first two weeks post onset. Subsequent pair-wise 
comparisons to examine changes on each measure from 24 hours to 1 week, 1 week to 2 
weeks, and 24 hours to 2 weeks revealed that changes were significant for all measures 
from the 24 hour to the 1-week evaluation and from the 24 hour to the 2-week evaluation. 
Pair-wise comparisons from the 1 week to the 2-week evaluation approached significance 
for the FDR task and reached significance for the objective indices associated with the 
PD task as reflected by the scores for the %IU and WPM measures. These results are in 
agreement with several studies that have documented relatively robust improvements in 
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speech and language in patients with aphasia in the early post onset period, a time when 
many patients are undergoing spontaneous recovery (Culton, 1969; Hartman, 1980; 
Pederson et al, 1995). While the present study corroborates earlier findings, it also 
provides evidence that spontaneous recovery begins quite early and can be objectively 
measured in acute ischemic stroke patients with aphasia. 
 
Table 4. 1   Mean scores, (standard deviations), and p values for all participants 
(n=26) for Forward Digit Repetition (FDR), Polysyllabic Word Repetition (PWR), 
Percent Information Units (%IUs), Words Per Minute (WPM), and Picture Naming 
(PN) for the 24 Hour, 1 Week, and 2 Week Assessments 
Measure 24H (1) 1 WEEK (2) 2 WEEK (3) Sig. 1 to 2 2 to 3 1 to 3 
FDR 37.2 (40.6) 52.2 (41.3) 61.6 (37.5) p=.00* p=.03* p=.12 p=.00* 
PWR 1.9 (1.7) 3.1 (1.7) 3.2 (1.7) p=.00* p=.00* p=.21 p=.00* 
%IUs 23.6 (32.6) 36.1 (37.6) 52.4 (37.6) p=.00* p=.08* p=.04* p=.00* 
WPM 28.1 (29) 35.7 (31.3) 44.9 (34.4) p=.01* p=.02* p=.08* p=.01* 
PN 37.6 (40.3) 59.2 (40.4) 58.8 (42) p=.00* p=.00* p=1.0 p=.01* 
*alpha 0.10 
Question 2: Do persons with aphasia following a first-ever left hemisphere 
ischemic stroke who do and do not receive tPA exhibit differences in speech and 
language recovery in the first two weeks post onset?  
This question addressed the possibility that the restoration of blood flow through 
administration of tPA to a stroke survivor with aphasia might result in better speech and 
language outcomes as compared to individuals not receiving tPA. Before examining any 
differences in language performance between participants who did (n = 13) and did not 
(n=13) get tPA, however, independent two sample t-tests were used to explore the 
possibility that the groups might differ on selected variables that could potentially impact 
speech and language outcomes. Table 4.2 shows the means and standard deviations for 
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the two groups for age and educational level, scores for the Charlson Comorbidity Index, 
polypharmacy, NIHSS stroke scale, and NIHSS language scale (at admission and at 24 
hours). None of the two sample t-tests supported differences between the groups for any 
of the variables shown in Table 4.2. It does appear, however, that overall scores of stroke 
severity and language subscale scores on the NIHSS made by neurologists and/or nurses 
reflected that initially, the tPA group sustained more severe strokes. Additionally, for the 
discourse task, it is important to note that percent information units can be impacted by 
the total number of words produced by the individual. For this reason, the total number of 
words for each participant on this task at each assessment was calculated and no 
significant differences between groups were observed.  
 
Table 4. 2  Means, standard deviations, and p values of demographic, medical, and 
therapeutic variables for participants who did receive tPA (n=13) and who did not 
receive tPA (n=13) 
Variable Group Mean SD p value 
Age tPA  69.5 14.5 .67 
Non-tPA  71.8 12.4 
Education tPA  2.4 .9 .85 
Non-tPA  2.3 1.7 
Comorbidity Index (CCI) tPA  .5 .9 .31 
Non-tPA  1.1 1.6 
Polypharmacy  
(% positive) 
tPA .3 .5 .25 
Non-tPA .5 .5 
NIH Total Admission  
(Possible score: 0-42) 
tPA 12.3 5.2 .19 
Non-tPA 9.3 6.4 
NIH Total 24 Hours  
(Possible score: 0-3) 
tPA 9.8 7.1 .39 
Non-tPA 7.5 5.7 
NIH Lang Admission  
(Possible score: 0-42) 
tPA 2.1 .8 .58 
Non-tPA 1.9 .6 
NIH Lang 24 Hours  
(Possible score: 0-3) 
tPA 1.8 .7 .43 
Non-tPA 1.6 .7 
*alpha 0.10 
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A repeated measures MANOVA was utilized to answer Question 2 and 
investigate the interaction of a within-subjects factor of time with a between-subjects 
factor of tPA. Results, as indicated in Table 4.3, show that for four of the five outcome 
measures (PWR, %IUs, WPM, PN), there was no significant effect of tPA or interaction 
between time and tPA. For FDR, there was a significant interaction of time and tPA 
detected at p=.08. Post hoc independent two sample t tests were used to analyze between-
subject group differences for this measure, revealing no significant group differences at 
any of the three assessments [24 Hour (p=.69), 1 week (p=.79), 2 week (p=.34)].  
 
Table 4. 3   p values for MANOVA on each outcome measure across assessments at 
24 Hours, 1 Week, and 2 Weeks for all participants (n=26) 
 
Measure Time p value tPA p value Time*tPA p value 
FDR .00* .55 .08* 
PWR .00* .71 .11 
%IUs .00* .65 .79 
WPM .01* .99 .37 
PN .01* .21 .54 
*alpha 0.10 
 
Because the MANOVA did not reveal any significant group differences, mean 
scores are provided as additional descriptive information. Table 4.4 shows the mean 
scores and standard deviations for each of the five outcome measures for the 24 hour, 1 
week, and 2 week assessments for the groups who did and did not receive tPA. The 
means for both groups align with the results for Question 1, revealing improvements 
made from 24 hours to 2 weeks, regardless of tPA status. A visual representation of 
changes over time by each group is provided for FDR (Figure 4.1), PWR (Figure 4.2), 
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%IUs (Figure 4.3), WPM (Figure 4.4), and PN (Figure 4.5). As seen in these graphs, for 
FDR, PWR, and WPM, group means were variable and the non-tPA group actually 
exhibited the same or higher scores compared to the tPA group at some assessments. 
However, for the %IUs and the PN tasks, the tPA group consistently performed better at 
every assessment. To provide additional descriptive information about the participants’ 
performance on these speech and language tasks, the mean amount of change for each 
group was also calculated for each measure, as reflected in Table 4.5. For the mean 
scores on all measures, it is also important to highlight that during the first two weeks, the 
standard deviations around the means are very large for both groups, emphasizing the 
large variability in performance within the sample. 
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Table 4. 4  Mean scores and standard deviations for participants who did receive 
tPA (n=13) and who did not receive tPA (n=13) for Forward Digit Repetition (FDR), 
Polysyllabic Word Repetition (PWR), Percent Information Units (%IUs), Words 
Per Minute (WPM), and Picture Naming (PN) for the 24 Hour, 1 Week, and 2 Week 
Assessments 
 
Outcome measure Group Mean SD 
FDR 24 Hours tPA  27.7 37.8 
Non-tPA  35 42.2 
FDR 1 Week tPA  55.3 40.3 
Non-tPA  50.2 43.6 
FDR 2 Weeks tPA  55.4 37.8 
Non-tPA  59.4 37.8 
PWR 24 Hours tPA  1.9 1.9 
Non-tPA  1.6 1.7 
PWR 1 Week tPA  2.8 1.9 
Non-tPA  3.1 1.7 
PWR 2 Weeks tPA  3.2 1.8 
Non-tPA  3.2 1.5 
% IUs 24 Hours tPA  24.4 33.8 
Non-tPA  15.6 28.8 
% IUs 1 Week tPA  40.2 36.3 
Non-tPA  34.9 39.8 
% IUs 2 Weeks tPA  55.4 34.8 
Non-tPA  42.4 39.3 
WPM 24 Hours tPA  29.8 32.7 
Non-tPA  21.3 22.9 
WPM 1 Week tPA  34 35.5 
Non-tPA  34.3 25.3 
WPM 2 Weeks tPA  46.2 38.1 
Non-tPA  43.1 26.2 
PN 24 Hours tPA 42.5 43.3 
Non-tPA 21.5 34.1 
PN 1 Week tPA 70 38.4 
Non-tPA 42.9 38.9 
PN 2 Weeks tPA 69.6 37.9 
Non-tPA 40.9 40.6 
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Table 4. 5  Mean change scores and standard deviations from 24 Hours to 2 Weeks 
for participants who did receive tPA (n=13) and who did not receive tPA (n=13) for 
Forward Digit Repetition (FDR), Polysyllabic Word Repetition (PWR), Percent 
Information Units (%IUs), Words Per Minute (WPM), and Picture Naming (PN)  
 
Outcome measure Group Mean Change SD 
FDR 
24 Hours to 2 Weeks 
tPA 26 26.2 
Non-tPA 28 25.3 
PWR 
24 Hours to 2 Weeks 
tPA 1.3 1.4 
Non-tPA 1.3 1.1 
% IUs 
24 Hours to 2 Weeks 
tPA 32.5 31.2 
Non-tPA 24.9 28.2 
WPM 
24 Hours to 2 Weeks 
tPA 17.4 24.1 
Non-tPA 17.1 17.2 
PN 
24 Hours to 2 Weeks 
tPA 27.9 34.1 
Non-tPA 15.5 22.5 
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Question 3: Do persons with aphasia resulting from a first-ever ischemic stroke 
who do and do not receive tPA differ on speech, language and quality of life measures at 
three months post onset, after receiving speech and language therapy? 
Eleven of the 26 study participants completed the 3-month assessment. Six of 
these participants received tPA and five did not. All 11 participants received varying 
amounts of speech and language therapy between their 2-week and the 3-month 
assessments in rehabilitation centers, via home health services, or on an outpatient basis. 
It was not possible to control the type or amount of speech and language therapy given to 
these participants. The investigator was, however, able to determine the number of hours 
spent in speech and language therapy by each of these participants. The results of several 
analyses examining differences in speech and language and quality of life outcomes for 
these two groups follow. 
Table 4.6 shows the mean change scores and standard deviations for the tPA 
(n=6) and non-tPA groups (N=5) for each language task from the 24 hour to the 3 month 
assessment, and from the 2 week to the 3 month assessments. Table 4.7 shows the mean 
scores and standard deviations for the speech and language tasks for the tPA (n = 6) and 
non-tPA (n = 5) groups that completed the 3 month assessment. Figures 4.6 and 4.7 also 
provide illustration of group mean differences for each outcome measure at three months. 
Mean scores for all five outcome measures were higher in the tPA group compared to the 
non-tPA group at three months (Table 4.6). However, when considering the mean amount 
of change on each measure, the tPA group demonstrated a smaller change score 
compared to the non-tPA group on some tasks (Table 4.7). This may be reflective of the 
variability of the sample, with some individuals starting at a higher ability level.  
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To answer Question 3, a MANOVA was utilized first to examine the interaction 
of a within-subjects factor of time, at 24 Hours, 2 Weeks, and 3 Months, and a between-
subjects factor of tPA. Results of this analysis, shown in Table 4.8, revealed that the 
entire sample improved significantly over time on all five outcome measures. With a 
between subject factor of tPA, there was a significant difference detected, indicating a 
significant impact of tPA, on the %IUs, WPM, and PN measures. Post hoc testing was 
then completed using independent two sample t tests to further investigate group 
differences on these three measures, with both the mean change scores and mean scores.  
For the mean change scores from 24 Hours to 3 Months and 2 Weeks to 3 Months, no 
significant group differences were identified on %IUs, WPM, or PN (Table 4.6). 
However, when examining the mean scores at three months on these three outcomes, 
results revealed that scores were significantly higher for the tPA group on each task 
(Table 4.7). Thus while the mean scores for all the language tasks for the participants that 
received speech and language therapy between the 2-week and the 3-month assessments 
were higher for the participants getting tPA (See Table 4.7), the mean amount of change 
up to 3 months on the various language measures was not significantly different for the 
two groups (See Table 4.6).  
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Table 4. 6  Mean change scores, standard deviations, and p values from 24 Hours to 
3 Months and 2 Weeks to 3 Months for participants who did receive tPA (n=6) and 
who did not receive tPA (n=5) for Forward Digit Repetition (FDR), Polysyllabic 
Word Repetition (PWR), Percent Information Units (%IUs), Words Per Minute 
(WPM), and Picture Naming (PN) 
 
Outcome measure Group Mean Change SD p value 
FDR 
24 Hours to 3 Months 
tPA 35.8 28.8 NR 
Non-tPA 18.6 20.1 
PWR 
24 Hours to 3 Months 
tPA 2.3 1.7 NR 
Non-tPA 2.3 1.6 
% IUs 
24 Hours to 3 Months 
tPA 42.0 33.9 .86 
Non-tPA 39.4 23.3 
WPM 
24 Hours to 3 Months 
tPA 47.2 25.5 .46 
Non-tPA 35.8 23.4 
PN 
24 Hours to 3 Months 
tPA 60 38.5 .41 
Non-tPA 40 38.1 
FDR  
2 Weeks to 3 Months 
tPA 11.3 16.4 NR 
Non-tPA -2.6 4.1 
PWR 
2 Weeks to 3 Months 
tPA .67 .75 NR 
Non-tPA .72 .83 
% IUs 
2 Weeks to 3 Months 
tPA 18.8 19 .41 
Non-tPA 10.8 15.2 
WPM 
2 Weeks to 3 Months 
tPA 21.9 23.1 .74 
Non-tPA 17.2 22.1 
PN 
2 Weeks to 3 Months 
tPA 15 19.7 .82 
Non-tPA 18 23.9 
*alpha 0.10 
NR- not reported; based on MANOVA results 
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Table 4. 7  Mean scores, standard deviations, and p values for participants who did 
receive tPA (n=6) and who did not receive tPA (n=5) for Forward Digit Repetition 
(FDR), Polysyllabic Word Repetition (PWR), Percent Information Units (%IUs), 
Words Per Minute (WPM), and Picture Naming (PN) for the 3 Month assessment 
 
Outcome measure Group Mean SD p value 
FDR 
3 Months 
tPA 64.8 30.5 NR 
Non-tPA 48.8 38.2 
PWR 
3 Months 
tPA 4.7 .49 NR 
Non-tPA 4.0 .67 
% IUs 
3 Months 
tPA 83 3.4 .01* 
Non-tPA 43.4 30.3 
WPM 
3 Months 
tPA 93.1 18.9 .01* 
Non-tPA 52.4 21.6 
PN 
3 Months 
tPA 100 0 .03* 
Non-tPA 52 45.5 
*alpha 0.10 
NR- not reported; based on MANOVA results 
 
 
Table 4. 8  p values for MANOVA on each outcome measure across assessments at 
24 Hours, 2 Weeks, and 3 Months for all participants (n=11) 
 
Measure Time p value tPA p value Time*tPA p value 
FDR .01* .52 .31 
PWR .02* .37 .80 
%IUs .01* .08* .62 
WPM .01* .02* .82 
PN .02* .04* .29 
*alpha 0.10 
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The statistical significance detected on certain tasks may reflect upon the 
sensitivity of those tasks to capture subtle improvements over time.  Specifically, 
information units, word repetition, and confrontational naming may better capture 
improvement in functional communication after stroke. Of note, because of the small 
sample of participants that completed this three month assessment, these results are 
interpreted with caution, simply suggesting evidence that tPA results in better speech and 
language outcomes at three months, rather than definitive proof. 
Although not significant, it is important to highlight that the tPA group in this 
sample had more severe strokes, as indicated by a higher total NIHSS score [tPA group: 
14(6); non-tPA group: 8.8 (8.3); (p=.26)]. However, while the NIHSS total score was 
higher for the tPA group on admission, the NIH language score was higher at admission 
for the non-tPA group [tPA group: 2.0 (.63) and non-tPA group: 2.2 (.83); (p=.66)]. This 
suggests a greater severity of stroke in the tPA group when considering overall 
impairments; but specific to language, there was a higher level of impairment in the non-
tPA group at onset.  Also, the tPA group received more total hours of speech therapy 
[tPA group: 18.6(10.7) and non-tPA group: 6.6 (8.2); (p=.07)] by three months, which 
was noted to be statistically significant. This is a very important factor to consider in the 
performance of both groups and is also considered in the regression analysis presented 
later. The distribution of therapy hours was not specifically tracked but was noted to be 
variable across participants. While some participants received more intensive therapy 
earlier within the three month timeframe, the therapy hours for others were more spread 
out across the three months.  
 
59 
  
The 11 participants available for the three month assessment completed the Stroke 
and Aphasia Quality of Life Scale (SAQOL-39), a standardized quality of life measure 
for individuals with stroke and aphasia. Three scores were calculated for each participant 
at this time: Total score, Communication domain score, and Psychosocial domain score. 
Table 4.9 and Figure 4.8 indicate that the Total and Psychosocial scores were very similar 
for both the tPA and non-tPA groups. As seen in Table 4.9, independent two sample t 
tests revealed no statistical differences in the scores. Interestingly, the non-tPA group had 
a slightly higher Total score at 3.9 (.98) versus the tPA group at 3.8 (.82).  The difference 
in Communication score, however, was statistically significant for the tPA group at 3.7 
(.82) compared to a 2.8 (.66) for the non-tPA group (p=0.10). Differences between 
groups suggest higher self-perceived quality of life regarding communication abilities at 
three months after stroke for those that receive tPA, but not necessarily in regard to 
overall function.  
 
Table 4. 9  Mean scores, standard deviations, and p values for participants who did 
receive tPA (n=6) and who did not receive tPA (n=5) for Stroke and Aphasia 
Quality of Life Scale (SAQOL-39) at 3 Months 
 
Outcome measure (n=11) Group Mean SD p value 
SAQOL-39 Total Score tPA 3.8 .82 .51 
Non-tPA 3.9 .98 
SAQOL-39 
Communication Score 
tPA 3.7 .82 .10* 
Non-tPA 2.8 .66 
SAQOL-39 Psychosocial 
Score 
tPA 3.4 1.2 .88 
Non-tPA 3.3 1.3 
*alpha 0.10 
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Secondary Question 
 
Question 4: In persons with first-ever left hemisphere stroke resulting in speech 
and language deficits, what other relationships are present between demographic, 
medical, and therapeutic variables and early speech and language recovery? 
The secondary question in the study investigates other possible relationships 
present among the group between speech and language recovery and quality of life scores 
and several demographic, medical and therapeutic factors. Multiple regression analyses 
were conducted to examine the relationship between each outcome measure and various 
potential predictors. With forward selection, the following were considered in the 
analysis: age, gender, education, co-morbidity index, polypharmacy, discharge 
disposition, acute care hospital length of stay, NIHSS total and language scores at 
admission, and total speech therapy hours at 2 weeks and 3 months. Multiple outcome 
measures were used in the analysis: 1) the change scores on each measure from 24 hours 
to two weeks, 2) the change scores on each measure from 24 hours to three months, 3) 
the two week means and 4) the three month means. The change scores were used to 
account for the different starting levels with high participant variability. However, the 
two week and three month means were also used to investigate predictive factors for the 
end performances at those times.  
Regression analysis revealed no significant predictive factors for several of the 
outcome measures. Age, gender, co-morbidities, polypharmacy, length of stay, and 
discharge disposition had no linear correlation and were not significantly predictive of 
performance on speech and language tasks or quality of life. However, as seen in Tables 
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4.10 and 4.11, results showed that the NIHSS scores, therapy amount at three months, 
education level, and tPA were all significant predictive factors across various outcome 
measures.  
Two Weeks: No significant predictive variables were identified for the change 
scores from 24 hours to two weeks. However, as seen in Table 4.10, for the mean scores 
at 2 weeks (n=26), on the PN task, a combination of the NIHSS Language admission 
score, tPA, and level of education accounted for 55% of the variance. The beta value 
indicates the amount that the outcome measure will increase with a one-point increase in 
the co-variant. The co-variant tPA was coded as 0 (non-tPA) and 1 (tPA), which means 
that use of tPA increased the PN score by 40.6% accuracy at two weeks. In addition, a 
one-point increase on the NIHSS language sub score decreased the PN score by 27.6%. 
At the same assessment point, the NIHSS Language score was also a significant 
predictive factor for %IUs, accounting for 17% of the variance with a beta value of -21.2, 
meaning a one-point increase in the NIHSS Language score resulted in a 21.2% decrease 
in IUs. 
Three Months: Table 4.11 shows that when examining change scores from 24 
hours to 3 months (n=11), the NIHSS Total admission score, or initial stroke severity, 
was a significant predictive factor of the amount of change for the PN task (R2=.450) and 
FDR task (R2=.583). The NIHSS Language score was predictive of amount of change on 
the PWR task at three months (R2=.366). tPA was a significant predictive factor in the 
three month mean score of percent information units and words per minute. With percent 
information units at three months, the tPA explained 53% of the variance within our 
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sample, with a beta value of 39.6, which means that use of tPA increased the overall PN 
score by 39.6% at three months.  
With WPM, two predictors, tPA and therapy amount at three months, were 
entered into the regression model. This model explained 78% of the variance, with a beta 
value in the model for tPA of 58.5. For this measure, the amount of therapy received at 
three months revealed a small beta and negative value of -1.47, indicating an increase in 
therapy hours resulted in a decrease in WPM mean score. For therapy amount at three 
months, no other significant correlations were identified with outcome measures. Finally, 
for the quality of life outcome measures, the NIHSS Language sub score was a 
significant predictive factor in the SAQOL-39 Communication domain score, accounting 
for 45% of the variance, a one-point increase in NIHSS Language score decreasing the 
Communication domain score by .87 points.  
 
Table 4. 10  Multiple linear regression for all participants (n=26) for 2 week means 
on Percent Information Units (%IUs) and Picture Naming (PN) 
 
Outcome Measure 
 
Variables R2 β 
IUs 
2 WEEK MEAN 
NIHSS Language Admission .17 -21.2 
PN 
2 WEEK MEAN 
NIHSS Language Admission, tPA, 
Education 
.55 -27.6 (NIHSS) 
40.6 (tPA) 
11.5 (Education) 
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Table 4. 11  Multiple linear regression for all participants (n=11) for 3 month means 
and 3 month change scores for Forward Digit Repetition (FDR), Polysyllabic Word 
Repetition (PWR), Percent Information Units (%IUs), Words Per Minute (WPM), 
Picture Naming (PN), and Quality of Life (QoL) measures 
 
Outcome Measure 
 
Variables R2 β 
IUs 
3 MONTH MEAN 
tPA .54 39.6 
WPM 
3 MONTH MEAN 
tPA; Therapy amount at 3 Months .78 58.5 (tPA) 
-1.47 (Therapy) 
FDR 
Change from 24H to 3M 
NIHSS Total Admission .58 2.69 
PWR 
Change from 24H to 3M 
NIHSS Language Admission .37 1.37 
PN 
Change from 24H to 3M  
NIHSS Total Admission .45 3.49 
QoL Communication 
Score  
3 MONTH MEAN 
NIHSS Language Admission .45 -.87 
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Chapter 5- Discussion 
 
This study examined early speech and language recovery in individuals with 
aphasia resulting from a first-ever left-hemisphere ischemic stroke and evaluated the 
effects of a single neuroprotective treatment, administration of tissue plasminogen 
activator (tPA) on recovery. From the standpoint of clinical management, this 
observational study sought to describe changes in speech and language during the acute 
phase of stroke recovery, so as to provide preliminary information to speech language 
pathologists about the prognosis and the evolution of patients with aphasia who do and do 
not receive this neuroprotective intervention. 
This study was unique in several respects. First, it constituted the first attempt to 
carry out a prospective study of the effects of a single neuroprotective treatment 
(administration of tPA) on a specific symptom (aphasia) associated with ischemic stroke 
with objective speech and language measures. Most studies investigating the effects of 
neuroprotective treatments on speech and language have been retrospective in nature or 
employed the NIH Stroke Scale to estimate stroke severity and severity of patients’ 
language deficits. Secondly, this study was a relatively large group study carried out in a 
reasonably sized southeastern medical center having a Comprehensive Stroke Program. 
Many studies examining the impact of neuroprotective treatment on speech and language 
functions have focused on single cases or small groups of patients. Lastly, this study 
utilized rigorous selection criteria such as limiting enrollment to individuals with first-
ever ischemic strokes. In many respects, the selection criteria employed in the study 
parallel those of two VA cooperative studies (Wertz et al, 1981; Wertz et al, 1986) that 
have been constituted as “the gold standard” for aphasia treatment outcome studies for 
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several years. This proved to be a challenge for completion of data collection but was 
important to maintain in order to provide the most homogenous sample possible. 
This chapter will begin with a discussion of findings and implications pertaining 
to the primary research questions posited in prior chapters as they relate to (1) speech and 
language changes in the acute phase of stroke recovery, (2) the impact of tPA on speech 
and language changes in the acute phase of stroke recovery, and (3) the potential effects 
of tPA on responsiveness of patients with aphasia to speech and language treatment. This 
will be followed by a discussion of how certain demographic, medical, and other factors 
might play a role in determining the impact of neuroprotective treatments such as tPA on 
speech and language outcomes, challenges of carrying out treatment research in the acute 
phase of stroke recovery, study limitations, and directions for further research. 
 
Speech and Language Changes in the Acute Phase of Stroke Recovery 
 
 Stroke recovery has recently be conceptualized in three phases, acute (onset to 1 
month post-onset), subacute (1 month to 3 months post-onset), and chronic (3 months 
post-onset and beyond), (Kiran, 2012). For many years, stroke survivors with aphasia 
received speech and language therapy in the acute and subacute phases of recovery, and 
sometimes into the chronic phase. Since the passing of the Balanced Budget Act (BBA; 
1997), however, decreasing acute care length of stays (LOS) and more prompt admission 
to the rehabilitation hospital have set the stage for most of a patient’s aphasia therapy 
being provided in the acute phase of stroke recovery. This implicates two factors in terms 
of measurement of early speech and language outcomes, spontaneous recovery and 
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aphasia treatment. Historically, the term spontaneous recovery has been used to refer to 
improvements in speech, language and other functions by stroke survivors in the absence 
of intervention (Brookshire, 2015). These improvements are thought to be the result of 
reduced edema, restoration of blood flow to damaged areas of the brain, and lessening of 
diaschesis associated with healing of the brain (Kertesz & McCabe, 1977; Rubens, 1977). 
Two periods of spontaneous recovery have been recognized, early and late. The former 
begins as soon as the 2nd or 3rd day post-onset (Rubens, 1977), lasts for approximately 
two weeks, and is characterized by robust improvements in speech, language, cognitive, 
and physical functions.  The later phase also lasts approximately two weeks and is 
characterized by more gradual changes in the aforementioned functions (Rubens, 1977; 
Pashek & Holland, 1988). 
 Not surprisingly, it is challenging to assess early speech and language changes in 
stroke patients with aphasia. Most patients with aphasia prefer to begin speech and 
language therapy in concert with other rehabilitation services as soon as possible after 
stroke. This complicates early measurement because one cannot determine if the changes 
are due to the healing powers of spontaneous recovery or the treatment the patient is 
receiving. Only three studies have assessed early speech and language outcomes for 
patients with aphasia in the absence of intervention (Culton, 1969; Hartman, 1981; 
Lendrum & Lincoln, 1985). All of these studies reported no significant changes in speech 
and language for untreated patients (Rosenbek, LaPointe, & Wertz, 1989) after 
approximately two months post-onset. Additionally, these studies completed their first 
measure nearer the end of the first month post onset whereas the present study assessed 
changes much sooner after stroke onset. 
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The findings of the present study provide new information regarding the 
timeframe for and degree of speech and language improvement in untreated aphasic 
patients in the acute phase of stroke recovery or what is also referred to as early 
spontaneous recovery. First, findings of this study indicate speech and language 
improvement in first-ever ischemic stroke patients with aphasia are discernable as early 
as 1 week post-onset (See Table 4.1). When changes on the FDR, PWR, %IU, WPM, and 
PN were examined for the 26 participants, irrespective of tPA status, significant 
improvements were noted for all five tasks from the 24 hour to the 1-week and 2-week 
assessments respectively.  While some of these patients received support, guidance, and a 
bedside evaluation from speech-language pathologists while in the acute care or 
rehabilitation hospital, study participants were essentially untreated during the first week. 
Thus, this study provides information regarding early changes in speech and language for 
untreated stroke patients with aphasia at a much earlier point than in prior studies. 
Significant improvement from the 1-week to the 2-week assessment was evinced for two 
of the five tasks. Participants received varying amounts of speech and language therapy 
during this timeframe, ranging from 0-6 total hours. While the sample was not 
completely untreated, it was not possible or ethical to totally prevent participants from 
getting any services of a therapeutic nature. Importantly, the significant improvements 
during this timeframe were on the measures associated with describing a picture, %IU 
and WPM, and changes in the modality deemed most important by patients and 
clinicians, talking. Improvements in speaking so early in the post-stroke course and at a 
time when many patients are still in the hospital suggest that speech-language 
pathologists in acute care settings should promote the use of conversation early as 
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suggested in many clinical papers directed at improving services to patients in the acute 
phase of stroke recovery (Beyn & Shokhor-Trotskaya, 1966; Holland and Fridriksson, 
2001; Marshall, 1997; Murray & Holland, 1995). While the frequency of acute care 
aphasia treatment sessions has decreased with healthcare reform, and are currently 
reported at an average of 1-3 sessions per week (Bernhardt, Chan, Nicola, & Collier, 
2007; Kong, 2011; McKenzie et al, 1993; Verna, Davidson, and Rose, 2009), the acute 
care speech-language pathologist should spend his or her limited time in supporting 
conversation and functional communication. This would also include providing education 
to the healthcare team on supporting language improvement through conversation during 
the acute care stay.  Finally, findings of this study provide added support to the premise 
that  speech and language improvements associated with spontaneous recovery in 
untreated patients are more or less confined to the first week post-onset and may dissipate 
earlier than has been previously thought. A much larger study by Pederson and associates 
provides some support (Pederson, Jorgenson, Nakayama, Raaschou, & Olson, 1995). 
These researchers, in a study of 330 patients with aphasia, found that 84% of the 
participants studied reached maximum improvement on a standardized Swedish language 
test at two weeks post-onset. Notably however, the Pederson study examined outcomes 
for both treated and untreated aphasic patients.  
Researchers have judiciously avoided investigating the impact of speech and 
language therapy in this early timeframe because of the impact and variability of 
spontaneous neurological changes. However, health care practices and reduced hospital 
length of stays now make it necessary to provide most of the treatment for an individual 
with aphasia in the acute phase of stroke recovery. This dictates the need to investigate 
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the combined influences of spontaneous recovery and the impact of early speech and 
language therapy. Results of the current study support the need for this.    
 
Determining the Impact of Neuroprotective Treatments in the Acute Phase of Stroke 
Recovery 
 
  Neuroprotective treatments have been shown to minimize the disabling 
consequences of stroke (NINDS, 1995; Hacke et al, 1995; Hacke et al, 1998; Hacke et al, 
2008; Clark et al, 2000; Clark et al, 1999; Goyal et al, 2015; Berkhemer, 2015; Saver et 
al, 2015). Nevertheless, these treatments are costly and involve risks, and empirical 
studies are needed to prove that neuroprotective treatments are efficacious in minimizing 
or preventing disability associated with residuals of a stroke beyond what might result 
without the treatment.  The present study examined outcomes for a single neuroprotective 
treatment, tPA, on early speech and language outcomes for patients with aphasia, a 
symptom associated with left-hemisphere stroke.  This study had a total of 26 study 
participants; 13 were administered tPA based on a neurologist’s decision, and 13 were 
not administered tPA. Two sample t-tests (See Table 4.2) were used to examine 
differences between the two groups for selected demographic (age, gender, level of 
education, Charlson Comorbidity Index, polypharmacy rating, NIHSS overall and 
language scale scores) and no group differences were found.  
Selected speech and language skills of participants who did and did not receive 
tPA were assessed three times in the first two weeks post onset, at 24 hours, 1-week, and 
2-weeks post-onset. Performance on five tasks, FDR, PWR, %IU, WPM, and PN tasks 
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was examined in two ways, between-group comparisons on each task (See Table 4.4) and 
mean change scores for the group on each task (See Table 4.5) with a series of separate 
statistical analyses. MANOVA results examining factors of time, tPA administration, and 
the interaction between these variables did not reveal any significant differences (See 
Table 4.3) on the PWR, %IUs, WPM, and PN tasks, precluding the need to conduct any 
post hoc comparisons. Table 4.3 reveals that the time factor was significant for all tasks. 
The tPA factor was not significant for any task and the time by tPA interaction was 
significant only for the FDR task. Post hoc testing for FDR revealed no group differences 
on this task at any assessment.  
Essentially, when examining the data, between group comparisons for mean 
scores and change scores for tPA and non-tPA groups duplicate those for the study 
sample as a whole (See Table 4.1). That is, participants improved across the three 
assessment points, 24 hours, 1 week, and 2 weeks on all measures. Figures 4.1, 4.,2, 4.3, 
4.4, and 4.5 provide a visual representations of the performance of the tPA (blue) and 
non-tPA (red) groups for the FDR, PWR, %IU, WPM, and PN tasks for the 24 hour, 1 
week, and 2 week assessments respectively. Here it can be seen that the difference in 
performance over time between the two groups is minimally discernible. In fact, at some 
assessment points, the non-tPA group had a higher mean score than the tPA group on the 
FDR, PWR, and WPM measures. One notable exception is the PN task. Although 
performance in picture naming of items from the Philadelphia Naming Test did not differ 
significantly between the tPA and non-tPA groups, the scores for this task as shown in 
Figure 4.5 appear to be strikingly different and much higher for the tPA group.  
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Findings of this study suggest that it may not be possible to detect the effects of a 
neuroprotective treatment such as tPA on the speech and language outcomes of stroke 
patients with aphasia in the first two weeks post-onset. While other studies have revealed 
a significant impact of tPA on speech and language recovery, as evidenced by changes in 
the NIHSS scores, within the first two weeks (Denier et al, 2015; Kremer et al, 2013), the 
current study does not corroborate those findings with use of objective speech and 
language assessments. There are a number of possible explanations for this. One 
noteworthy explanation is the variability in performance on all of the speech and 
language measures for individuals in the tPA and non-tPA groups. This is clearly evident 
in the large standard deviations for all mean scores (See Tables 4.2, 4.4, and 4.5). Lesion 
size and site may also contribute to the variability but were not analyzed in this study and 
it would be informative to try to account for the influence of this factor in future studies. 
The fact that verbal tasks were selected as outcome measures may also have contributed 
to this variability, since the demand to produce verbal output for these individuals may be 
too difficult during this timeframe.  
The speech and language tasks were chosen because they are routinely used by 
SLPs to assess persons with aphasia at the bedside in the acute care hospital and spoken 
language expression is of the utmost importance to stroke survivors with aphasia. 
However, these tasks may be ill-suited for use with acute stroke patients with aphasia in 
the acute phase of stroke recovery, particularly when so many patients manifest co-
occurring motor speech deficit, not controlled for in this study. Perhaps, as measures such 
as eye tracking, auditory evoked potentials, and other indices that preclude making a 
verbal response, are adapted for use in clinical environments, these might be better tools 
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to assess the effects of neuroprotective treatments such as tPA in the time frame when the 
patient’s ability to respond verbally is limited. 
Variability of performance on the language tasks across all four assessments for 
all participants may also be attributed to the challenges of being in the acute care hospital. 
In the early post-onset period, hospitalized stroke patients frequently suffer bouts of 
fatigue as they are assailed with demands associated with medical care, laboratory tests, 
imaging and trying to recover from a near-death experience. Ideally, it would have been 
advantageous to assess all participants at the same time of day and control for a fatigue 
factor. This was, however, impossible to do and patients were assessed at times of the day 
convenient to the schedule of the   investigator and when participants were available.  
While the verbal tasks used in the study were sensitive to changes over time for 
all patients, they were not sensitive enough to discern differences in patients who 
received tPA. This calls into question the reliance on the language subscale of the NIHSS 
of 0 = none; 1 = mild; 2 = moderate-severe, and 3 = global as an indicator of aphasia 
recovery. Many previous tPA studies claim significant improvement in speech and 
language in patients with aphasia, even within one week of stroke onset, based on use of 
the NIHSS language score (Denier et al, 2015; Kremer et al, 2013; Lundstrom et al, 2015; 
Maas et al, 2012; Martins et al, 2017; Menier et al, 2010). While the overall scale does 
provide crucial ongoing assessment as a measure of global severity of stroke throughout 
the acute care stay, it provides only broad assessment of changes in aphasia. Moreover, 
while the NIHSS is considered the gold standard by medical professionals to document 
neurological improvements or declines over time, it does not offer detailed information 
about speech and language skills. Therefore, improvements identified by the NIHSS in 
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earlier studies may not provide the objective data to depict a patient’s ability to 
communicate and should be interpreted with some caution. 
In sum, while no differences in speech and language outcomes between patients 
receiving and not receiving tPA were found, this should not be interpreted to mean tPA 
does not impact speech and language outcomes for patients presenting with aphasia 
following a first-ever ischemic stroke. Rather it may indicate a need to further refine our 
measurement techniques and/or measure at different time. 
 
Impact of tPA on Speech and Language Therapy Outcomes and Quality of Life 
 
 Eleven participants completed the 3-month assessment. This assessment involved 
re-administration of the FDR, PWR, %IU, WPM, and PN tasks and completion of the 
Stroke and Aphasia Quality of Life Scale (SAQOL-39). The investigator’s intention was 
for all 26 participants to complete the 3-month evaluation, but three participants died, and 
12 were lost to follow up after the 2-week assessment. Of the 11 participants available for 
the 3-month evaluation, six received tPA and five did not. All 11 participants received 
speech and language therapy between the 2-week and the 3-month evaluation in varying 
amounts. Differences in the groups on the various speech and language outcome 
measures and the SAQOL-39 scale were examined to ascertain the potential impact of 
tPA on treatment outcomes.  
 
 
75 
  
tPA and Therapeutic Outcomes 
 
 To investigate the impact of tPA on the 3-month outcomes of the tPA group (n=6) 
and non-tPA group (n=5), a MANOVA was first used to examine a within-subjects factor 
of time (24 hours, 2 weeks, and 3 months), a between-subjects factor of tPA, and the 
interaction of these two factors. As presented in chapter 4, results of this analysis 
revealed that the sample of 11 participants improved over time on all five outcome 
measures and the between-subject factor of tPA was significant for % IUs, WPM, and 
PN. When group mean scores were compared on these three speech and language 
outcome measures at 3 months post-onset and after the participants had finished their 
speech and language therapy course, the tPA group evinced significantly higher scores on 
the same three outcome measures as shown in Table 4.7. These results suggest that tPA 
may positively impact responsiveness of patients with aphasia to speech and language 
therapy, but they warrant cautious interpretation because of the small sizes of the groups 
and the differences in amount of therapy received by each group. Results also indicate 
that it might be advantageous to assess the effects of neuroprotective treatments such as 
tPA later rather than sooner as there were relatively few differences between subjects 
getting and not getting tPA until the 3 months evaluation. Strategies for accomplishing 
this and a rationale for examining the effects of neuroprotective treatment in the long 
rather that the short term will be presented in a subsequent segment of the discussion on 
research implications.  
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Quality of Life 
 
 Differences in self-perceived quality of life on the total and psychosocial scores of 
the SAQOL-39 between the tPA and Non-tPA groups after therapy were not significant, 
but nearly identical, as seen in Figure 4.8. However, the mean communication score on 
the SAQOL-39 was significantly higher for the participants that had tPA. The disparity in 
the mean communication score on the SAQOL-39 for the groups may reflect the fact that 
the tPA group had received significantly more hours (p =.07) of speech and language 
therapy (Mean =18.6 hours; SD=10.7 hours) than the non-tPA group (Mean = 6.6 hours; 
SD = 8.2 hours) at 3 months post-onset.  Since participants in both groups were aphasic 
and severity of aphasia did not differ for the groups as determined by language scores on 
the NIHSS at the time of hospital admission, it raises the question of why the tPA group 
received significantly more therapy. Although speculative at this time, the differences in 
the speech and language treatment hours for the groups and the possible impact of these 
hours on the communication score for the SAQOL-39 may reflect the amount of time 
spent in the rehabilitation hospital by members of each group. Examination of the total 
NIHSS scores for the participants completing the SAQOL-39 scale after speech and 
language therapy revealed that the mean total score for the tPA group on the NIHSS  
(Mean = 14; SD = 6) suggests that they had incurred more severe strokes than the non-
tPA group (Mean = 8.8; SD = 8.3). This may have caused them to spend a longer amount 
of time in the rehabilitation hospital and to have logically received more therapy. 
Subsequently, the extended time in speech and language therapy may have positively 
influenced their self-perception of communication skills.  
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Regression Analysis 
 
 In the regression analysis completed in this study, various factors and their impact 
on outcome measures were included for consideration. The only significant factors that 
emerged were tPA, stroke severity, level of education, and total therapy hours at three 
months. In contrast to previous studies (Chapey, 2008; Goldstein, 1995; Goldstein, 1998; 
Holland et al, 1989; Ogrezeanu et al, 1994; Sarno et al, 1992), age, gender, comorbidities, 
and medications were not identified as significant factors in recovery.  
An important result central to the aim of this study was the fact that tPA was 
significant to predict performance on picture naming and discourse tasks at varying 
assessment points. Of note, tPA generally had large beta values, indicating that the use of 
tPA resulted in large increases in outcome scores. This is particularly true with the PN 
task means at 2 weeks and the discourse tasks at 3 months, supporting the theory that 
these verbal output tasks appeared to be most sensitive to change after tPA. In fact, the 
beta value for tPA as a predictive factor of the mean %IU at 3 months was nearly 40. An 
increase of 40% more relevant, informative content in a language sample can make a 
substantial difference in the functional communication and independence of an individual 
with aphasia. This provides additional support for the later effects of tPA with regard to 
speech and language recovery. 
  Another significant factor in recovery in this study was initial stroke severity and 
initial aphasia severity, represented as two separate scores by the NIHSS upon admission 
to the acute care hospital. It is well-established (Inatomi et al, 2008; Kertesz & McCabe, 
1977; Lazar et al, 2010; Hojo et al, 1985; Plowman et al, 2011) that the severity of 
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aphasia at onset significantly correlates with both early and long-term improvement of 
aphasia and this study continues to validate that finding.   
 As mentioned earlier, the differences in speech, language, and quality of life 
outcomes between groups at three months should be interpreted with caution because of 
both the small sample size and the fact that the tPA group received significantly more 
hours of speech and language therapy. Further analyzing this as a potential variable, the 
total amount of hours in therapy was included as a predictive factor in the regression 
analysis. Interestingly, this variable was only a significant predictor of the mean WPM 
score at 3 months and actually had a negative predictive value, with a small beta of -1.47. 
This indicates that an increase in therapy hours resulted in a decrease in WPM mean 
score, which is in direct contrast to the expected impact. For therapy amount at three 
months, no other significant correlations were identified with outcome measures, 
suggesting that the impact of speech and language therapy on these 3-month outcomes 
warrant further consideration and analysis.  
 
Limitations 
 
The number of early treatment outcome studies involving individuals with aphasia 
is minimal due to some very real hurdles. Logistical challenges and limitations are 
highlighted by the current study, substantiating the lack of evidence in this area. 
First, the small sample size in this study may have impacted the results, especially 
considering the large amount of variability within the sample. An a priori sample size 
analysis was completed and I was able to recruit the calculated 13 per group for 80% 
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power, so we can be confident in significance testing completed for the study. However, 
increasing the sample size would have increased the homogeneity of each group, 
providing a more representative sample of the population to study. The small sample size 
at the 3-month follow up is a further limitation. The results suggest evidence that by this 
assessment, tPA has significantly improved the speech and language skills of those that 
received it. However, due to the small groups, it is impossible to state this fact 
confidently. Considering the findings, a larger study would certainly be justified and 
warranted.  
The sample size in this study was highly impacted by challenges with recruitment. 
The inclusion criteria were a major impediment to recruitment. Of more than 600 patients 
screened over 2.5 years, only 32 met inclusion criteria. Over 30% (214) had suffered a 
prior stroke, excluding them from this study. It is very common for a person admitted 
with stroke to have a previous history of stroke but this inclusion criterion was very 
important to maintain in order to rule out any residual effects of the prior infarct, 
potentially confounding the results. The recruitment challenges in this study are 
consistent with previous studies limited by rigorous inclusion criteria. For example, Nesi 
et al (2012) screened 2350 potential participants over the course of seven years, with only 
128 meeting criteria to participate. Similarly, Denier et al (2015) needed five years to 
enroll 137 individuals with aphasia who received tPA, supporting that this particular 
challenge is common. 
In general, recruitment and conduct of early outcomes research can also be 
compromised due to other factors, such as the shortened length of stay for patients with 
stroke. Due to reimbursement changes, the person with a stroke is discharged from the 
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acute care hospital much more quickly than in the past. This can make studies with 
follow-up more challenging and difficult to complete, with a higher risk of attrition. Also, 
in this early window after stroke, prospective subjects can be difficult to approach early 
due to the gravity of the current situation, the myriad of procedures they are completing, 
or even simply fatigue. Some of these factors were present in the current study, 
specifically increasing the burden upon the investigator to complete assessments within 
the necessary timeframes.  
 Another limitation is the fact that this study included participants admitted with a 
diagnosis of stroke to a single hospital. This limited the application of the results to a 
single facility within a single geographical location, which may possibly introduce bias 
and limit generalizability of the results. For this reason, the study should be considered as 
exploratory and a first step in objectively evaluating early speech and language recovery. 
 Additional threats to internal validity include selection bias, repeated testing, and 
experimenter bias. Convenience sampling was used based on admissions to the medical 
center and was at times confined within the schedules of the investigator and research 
assistant. This may have inadvertently introduced some bias into the results. A testing 
effect may be present in the data as well since subjects received multiple assessments 
within a 2-week window of time. While the speech and language stimuli were presented 
in alternating fashion as much as possible, some of the tasks were presented in the same 
format at each assessment. As a result, familiarity with the testing stimuli could 
potentially introduce additional bias. Experimenter bias is also present as the primary 
investigator was the one collecting all data and scoring a portion of it. This was 
unavoidable, however, based on the design of the study and frequency of assessments.  
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  A final limitation includes the study’s inability to gather a true baseline 
assessment. The first assessment done with this sample was within 24 hours of stroke 
onset. Ideally, however, the first assessment would have occurred after stroke onset but 
before initiation of tPA. Considering the hospital’s prompt response time and process for 
medical diagnosis, an assessment by the speech pathologist just is not feasible that 
quickly (Maas et al, 2012). Moreover, previous studies (Kremer et al, 2013; NINDS, 
1995) have revealed insignificant changes within 24 hours of onset, particularly when 
comparing those who get tPA and those who do not, further justifying the decision to 
design the study with the first assessment after tPA but within 24 hours of stroke onset.  
 
Future Research Implications 
 
 Next steps in research following this current study would include expansion of the 
current investigation as well as replication with other outcome measures and other patient 
populations. First, I would like to continue to recruit and gather data on the current study. 
Increasing the sample size, as stated above, would only help to validate results and 
potentially reduce the variability and standard deviations within the sample data. If I 
could add more participants and complete the 3-month follow up, I may be able to more 
confidently report the significance in differences between the tPA and non-tPA groups at 
that assessment. Additional participants would help to further illustrate how these 
individuals are changing during the first two weeks and three months after their stroke. 
This could also include expansion in pursuing additional sites, in order to reduce some of 
the bias as discussed.  
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 In addition to increasing the sample size by continued recruitment, further 
analysis of already collected data would add to the initial interpretation. Some data were 
collected but, in order to keep the product of this study focused, were not included in 
statistical testing. For example, I would like to continue to review and analyze the amount 
of speech and language therapy received at 3 months by our participants. Although 
regression analysis did not reveal any positive relationship, a more detailed and 
individualized review of each participant may inform further statistical testing. Likewise, 
investigating the LOS in acute care and rehabilitation/extended care facilities, as well as 
differences between these discharge dispositions, could potentially provide more 
information about the impact of a comprehensive rehabilitation program on speech, 
language, and quality of life outcomes. Additionally, it would be important to consider 
the physical impairments for participants and the influence those may have on our results. 
Physical limitations negatively impact overall quality of life post stroke (Charfi et al, 
2017; De Wit et al, 2017; Ellis, Grubaugh, & Egede, 2013; Krzeminska, Bekus, 
Borodzicz, & Arendarczyk, 2016) and improvement of physical health significantly 
improves quality of life (Gordon, Wilks, & McCaw-Binns, 2013). The quality of life 
survey results in this study support the theory that physical impairments may be more 
important to perceived quality of life than communication. Although the physical domain 
SAQOL-39 scores were not included in analysis, this would be an important next step to 
investigate its potential impact on quality of life in the included sample. 
 Next, I believe it would be important to replicate this study with other outcome 
measures. While the current study focused solely on speech and language tasks that 
primarily assessed verbal expression, the same procedure could be completed with tasks 
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focused on auditory comprehension, written expression, and written comprehension. 
These four main modalities are often impacted by aphasia in varying degrees. The 
relationship of changes in one versus another after tPA may be of interest and have 
important clinical application.  
 Since the current study highlights the potential later effects of tPA on speech and 
language, it would also be important to complete a study with more longitudinal data. 
The timeframe of recovery in this study seems to align with previous studies finding that 
speech and language skills are later to respond to the tPA intervention. While studying 
dramatic recovery of individuals post tPA at the end of infusion, Felberg and colleagues 
(2002) observed a pattern of recovery with individual impairments. Gaze deviation 
recovery, sensory recovery, and motor leg movement were among the first to emerge 
while aphasia and dysarthria were the last impairments to recover.  Mukilik et al (2010) 
discovered a similar pattern with aphasia only partially responding to the tPA by the end 
of infusion while many other impairments resolved completely. Data from the current 
study support the theory that aphasia may have a later response time to tPA. The three 
month follow up as a stopping point, although consistent with other studies (Jacquin et al, 
2014; Kremer et al, 2013; Lundstrom et al, 2015) was a limitation of this study, given the 
fact that significant differences did not emerge in the groups until sometime between two 
weeks and three months.  In fact, based on the current results, a compelling study would 
be one in which the participants are recruited in the acute care hospital and intentionally 
matched on various factors. In contrast to the current study, the assessments would start 
after acute care discharge, with bimonthly or monthly assessments that continue until 
twelve months after stroke. This would provide an ongoing long-term investigation of 
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differences in groups after tPA, avoiding the early spontaneous recovery phase. I believe 
a study like this would provide very important evidence that could help clinicians in 
maximizing rehabilitation time and understanding expected prognosis.  
The current study focused solely on individuals who received intravenous tPA. 
However, use of endovascular treatment, or mechanical thrombectomy, as a neuro-
protective intervention is rapidly becoming the gold standard for treatment. The 
mechanical thrombectomy procedure is completed in the presence of an occlusion in a 
large blood vessel, or ELVO (Emergent Large Vessel Occlusion), and involves removal 
of the clot. It is commonly completed concurrently with administration of tPA but can be 
completed within a much larger timeframe, up to eight hours post onset. At the hospital 
where this study was completed, the rates of mechanical thrombectomy have increased 
exponentially since we began recruitment. Since the procedure was completed 
infrequently at the onset of the study, individuals who had this procedure were not 
included in the sample.     
Overall, use of mechanical thrombectomy has been found to be a superior 
treatment compared to tPA alone, with improved neurological outcomes based on the 
mRS (Goyal et al, 2015; Berkhemer et al, 2015; Saver et al, 2015) and functional 
independence scores, returning home more quickly (Campbell et al, 2015). Given the 
overwhelming evidence that endovascular treatment results in much different outcomes 
compared to tPA, future research in early speech and language recovery should include 
participants that receive thrombectomy. Gaining knowledge of the impact of these early 
neuroprotective interventions on early speech and language changes would be invaluable 
to acute care speech language pathologists. 
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Finally, the current study did not investigate the impact of any psychosocial 
factors on early recovery of stroke. Basic demographic and medical variables were 
analyzed. However, the impact of social support was not considered in that analysis. 
When assessing overall functional status, strong social support after stroke results in 
decreased functional limitations (Colantonio, Kasl, Ostfeld, Berkman, 1993; Glass, 
Matchar, Belyea, & Fuessner, 1993), improved community participation (Beckley, 2007), 
and increased quality of life (Hilari & Northcott, 2006). The quantity and quality of the 
social network and its impact on early speech and language recovery after stroke has yet 
to be studied. Likewise, the relationship of the social network to the impact of tPA would 
be interesting to evaluate, adding more to the body of literature related to aphasia 
prognosis and early management by the speech language pathologist.   
  
Conclusion 
 
 This novel study was the first prospective investigation to evaluate the early 
speech and language outcomes of individuals who do and do not receive tPA in an 
objective, systematic method. Although some limitations are recognized, results validate 
early recovery of skills within the first two weeks, regardless of receipt of tPA and in the 
absence of any speech and language therapy. Differences between those who got tPA and 
those who did not were not significant until after the two week assessment. By three 
months, it appears that individuals who did receive tPA have significantly improved 
outcomes and higher self-perceived quality of life related to communication abilities. 
Helping inform speech language pathologists in this early timeframe, the results add to 
the small body of literature focused on the acute phase of aphasia recovery.  
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Appendix A- CID Everyday Speech Sentences (Dais and Silverman, 1978) 
 
Instructions: The researcher will read the following sentences aloud to participants. 
Participants will repeat sentences verbatim.  
Passing Criterion: 9/10 correct 
ITEM Correct Incorrect 
1. It’s time to go.   
2. If you don’t want these old 
magazines, throw them out.  
  
3. Do you want to wash up?   
4. It’s a real dark night so watch your 
driving. 
  
5. I’ll carry the package for you.   
6. Did you forget to shut off the 
water? 
  
7. Fishing in a mountain stream is my 
idea of a good time. 
  
8. Fathers spend more time with their 
children than they used to.  
  
9. Be careful not to break your 
glasses.  
  
10. I’m sorry.    
TOTAL   
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Appendix B- Vision Screening 
 
 
 
VISION SCREEN 
 
Name:    Date:    
 
Circle the word good each time you see it. Read left to right. 
 
 good  
breath good take moth home good 
bye one good good bee ·shine 
good good baby house shirt good 
see nose good good hope fine 
good show tired pies seem good 
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Fig. 16.9. Word scanning/cancellation task for vision screening. (From 
Augmentative and Alternative Communication. Copyright © 1998 by David 
Beukelman & Pat Mirenda.) 
 
 
 
 
 
 
 
 
 
 
good 
 
paste 
table 
 
good 
shine 
 
glue 
carpet 
 
time 
good 
 
girl 
good 
 
gone 
team 
 
good 
good born shout socks pick tone glow 
glow good point there see good pass 
 
good 
 
table 
 
shine 
 
carpet 
 
good 
 
good 
 
team 
paste good glue time girl gone good 
good bom shout socks pick tone glow 
glow good point there see good pass 
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Appendix C: Forward Digit Repetition 
 
Instructions: 
• Participant was informed that he or she would be read a list of numbers aloud by 
the examiner and that he or she was to repeat the numbers as best as possible 
 
Number Lists Used 
5-digit 
 
6-digit 
 
7-digit 
 
4-7-2-9-8 
3-7-0-9-1 
5-2-2-6-8 
9-6-7-3-5 
1-6-3-8-0 
 
7-0-6-3-5-1 
4-6-2-8-9-3 
6-5-8-2-1-4 
2-2-4-7-9-5 
5-0-7-3-1-3 
 
2-3-0-5-4-8-2 
9-6-7-3-2-7-5 
5-3-6-8-6-3-0 
2-1-8-0-8-7-6 
4-6-7-7-1-9-3 
 
 
 
Data Collection 
• All digit sets presented verbally 
• Stimulus and response both audio-recorded 
• No prompting or repetition provided 
• Termination criteria: Error on five consecutive sets 
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Scoring Procedures 
• Scorer blinded to participant and assessment point 
• Participant was given credit for any digit in the string repeated in the correct 
location of the series. For example, if asked to repeat “2-5-8-4-7,” the response 
was “4-5-4-4-7,” the subject was credited for repeating three of the five members 
of the digit string correctly (see underlined items). 
• Because not all participants were able to repeat six or seven digit strings, a post-
hoc decision was made to score this task for accuracy for the five digit strings 
only. In the final analysis, FDR scores represented the number of digits repeated 
correctly for the five sets of five-digit stimuli. This provided a percentage of 
accuracy for X/25. 
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Appendix D: Polysyllabic Word Repetition 
 
Instructions:  
• Participant was instructed that the examiner would say some words one-at-a-time 
and he or she was to repeat the word after the examiner as best as possible.  
 
Word List Used 
1. Animal 
2. Snowman 
3. Artillery 
4. Stethoscope 
5. Rhinoceros 
6. Volcano 
7. Harmonica 
8. Specify 
9. Statistics 
10. Aluminum 
 
Data Collection 
• Each word presented verbally for immediate repetition 
• Only the participant responses were audio-recorded 
• The same ten words were presented for each assessment, but in a different order 
• Termination criteria: The task was terminated if the participant failed to respond 
or indicated that he or she could not respond to five consecutive words 
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Scoring Procedures 
• Responses were scored using a 0-5 point scale from the Everyday Speech 
Production Assessment Measure (E-SPAM; Watts, Marshall, Olson, & Kleinert, 
2014), shown below 
• To calculate the participant’s score for this task, ratings were summed and 
averaged. Items not responded to were scored as “no response” 
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E-SPAM Scoring Scale 
Score Description Details 
0 No Response The patient is unable to produce a verbal 
response, informs the examiner he/she cannot 
respond, or refuses to respond. 
 
1 Unrecognizable The patient produces a verbal response, but the 
response is not recognizable and offers the 
listener little-to-no basis for making a guess. 
 
2 Marginal The final response is produced with considerable 
effort and/or after much struggle and is only 
recognizable because the listener knows the 
target utterance; the listener would be able to 
select the target utterance from a list of choices.  
 
3 Approximated The final response is recognizable as the target 
response, but is altered prosodically, distorted, 
stiffly produced, or occurs after an effortful 
period of self-correction. Although the utterance 
is recognizable, it would always be perceived as 
abnormal by a listener.  
 
4 Corrected/Restarted The initial response is partially or completely 
incorrect, but the final response is normal in 
every aspect except for the fact that it occurred 
after a self-correction or re-start.  
 
5 Normal Normal response 
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Appendix E: Picture Description 
 
Instructions:  “I would like you to look at this picture and tell me about it. Try to use 
sentences and tell me what you see happening.” 
 
Pictures Used 
 
COOKIE THEFT PICTURE 
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PICNIC SCENE 
 
 
Data Collection 
• Narratives were audio recorded  
• Participants were given up to 1 minute to respond with each picture  
• Both pictures were attempted at each assessment, even if no verbal output was 
observed on the first picture 
• Pictures presented in counter balanced order at each assessment 
 
Scoring Procedures 
• Audio recording of each picture description transcribed verbatim 
• Transcription and scoring completed by trained research assistant 
• To calculate percentage of correct information units (%IUs):  
o Procedures used by Wright and Capilouto (2012)  
97 
  
o Each transcription assessed for total information units, “defined as a word 
that was intelligible, relevant, accurate, and informative relative to the 
stimulus” (p. 662) 
o Each transcription also assessed for total words 
 Intelligible 
 excluded if they were filler words or considered commentary on 
the stimulus/task 
o Total words divided by total information units, and multiplied by 100 to 
calculate the %IU.  
• To calculate words per minute (WPM):  
o Each sample was timed 
o Intelligible words per minute calculated by dividing the minutes spoken by 
the total words. 
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Appendix F: Picture Naming 
 
Instructions:  Participant was instructed that he or she would see individual pictures and 
they were to tell the examiner the name of the each picture. 
 
Pictures Used 
 
Set 1 
24 Hours 
Set 2 
1 Week 
Set 3 
2 Weeks 
Set 4 
3 Months 
Wagon Baby Thermometer Rake 
Monkey Scissors Piano Drum 
Spoon Tent Queen Table 
Ring Squirrel Butterfly Pig 
Hamer Foot Sandwich Camera 
Crown Candle Bone Flower 
Ghost Leaf King Cane 
Turkey Pillow Vest House 
Hat Bread Skull Duck 
Pumpkin Owl Horse Apple 
 
 
Data Collection  
• Ten individual pictures were presented at each assessment  
• Responses were audio recorded 
• Same set of pictures was used for each participant at the corresponding 
assessment 
• Each stimulus was provided for 10 seconds without any prompts or cues 
• Termination criteria: The task was terminated when there was no response on five 
consecutive pictures  
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Scoring Procedures 
• Responses were initially scored from the audiotapes using the 16-point 
multidimensional scoring system from the Porch Index for Communication 
Ability (PICA) (Porch, 1967) by a highly experienced clinician trained in use of 
the system. Since the PICA scoring system is descriptive rather than ordinal, it 
was felt it might provide a more sensitive indicator of naming ability. However, 
many of the participants were unable to name pictures accurately or respond to 
the task. Examination of the naming data revealed there was no advantage to 
scoring responses with the PICA system and a post-hoc decision was made to 
score naming responses right or wrong. A percentage of naming accuracy on the 
task was calculated for each subject.  
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Appendix G: Procedures/Script for Data Collection 
Subject: _______________________________ 
Date of completion: ___________________________   
Time after stroke (circle one):      w/i 24 hours          1 week          2 weeks          3 months 
 
“I am going to ask you some questions, look at some pictures, and say some things. I am 
going to turn on the audio recorder now.” 
• Turn on recorder. Place microphone 6 inches from patient’s mouth. 
 
“I am going to ask you some questions. Try to answer as best as you can.” 
• Circle whether the subject is able to answer. If the subject is nonverbal and 
unable to state name or date of birth, discontinue the rest of the questions.  
• Complete Short Portable Mental Status Questionnaire 
 
Vision and Hearing Screening (do only on initial timepoint) 
“Now I’m going to test your vision.” 
• Use vision screening task 
 “Now I’m going to test your hearing.” 
• Use OAE to screen hearing in both ears if participant is non-verbal 
• Use CID Everyday Speech Sentences if participant is verbal 
 
Do at each timepoint 
“I’d like you to try to repeat some things after me.” 
1. Present digit recall task 
• “I will read you a list of numbers. I want you to repeat the numbers as best 
as possible.” 
• If participant demonstrates error on 5 consecutive stimuli, discontinue task 
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2. Present polysyllabic words 
• “I will say some words one at a time. I was you to repeat the word the best 
that you can.” 
• If participant is unable respond on 5 consecutive words, discontinue task 
 
 
“Now I would like you to look at this picture and tell me about it. Try to use sentences 
and tell me what you see happening.” 
• Provide the cookie theft and the picnic scene picture for the patient to 
describe.  
• Allow one minute for participant to respond 
• Note which picture was presented first, alternate on assessments using 
data collection chart 
 
“I will show you some pictures and I want you to tell me the name of each picture.” 
• Philadelphia Naming Test 
o Practice items x 3 first- without recorder on 
o Use the PNT30a or 30b in sets of 10 
 Use the set denoted for each assessment 
o Allow 10 seconds with each picture. Do not provide prompts. Only 
provide general feedback “you’re doing fine” 
o If the subject is unable to produce any speech on 5 consecutive 
stimuli, discontinue naming testing.  
 
At three month timepoint 
Also provide QoL scale 
 
 
 
  
 
 
 
102 
Appendix H SAQOL-39 
Name/ID:___________________________ d.o.b.:____________  Δ:_________________
 Date:________________ 
SAQOL-39g Scoring Sheet 
 
DURING THE PAST WEEK (Repeat as in SAQOL-39) 
Item ID How much trouble did you have 
(Repeat before each item or as necessary) 
Couldn’t 
do it at all 
A lot of 
trouble 
Some 
trouble 
A little 
trouble 
No trouble  
at all 
Domain scores 
       Physical Comm. Psycho-social 
SC1. preparing food? 
 
 
 
1 
 
2 3 4 5    
SC4. getting dressed? 1 
 
2 3 4 5  
SC5. taking a bath or shower? 1 
 
2 3 4 5  
M1. walking? 
(If respondent can’t walk, circle 1 and go 
   
 
1 
 
2 3 4 5  
     M4.       keeping your balance when 
bending over or reaching? 
 
1 
 
2 3 4 5  
     M6.               climbing stairs? 1 
 
2 3 4 5  
M7.        walking without stopping to rest  or using a 
wheelchair without stopping to rest? 
 
1 
 
2 3 4 5  
M8.  standing? 
 
1 
 
2 3 4 5  
M9.       getting out of a chair? 
 
1 
 
2 3 4 5  
W1.  doing daily work around the house? 
 
1 
 
2 3 4 5  
W2.  finishing jobs that you started? 
 
1 
 
2 3 4 5  
UE1.     writing or typing, i.e. using your hand to 
write or type? 
 
1 2 3 4 5  
UE2.     putting on socks? 
 
1  2 3 4 5  
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UE4.     doing buttons? 
 
1 2 3 4 5  
UE5.     doing a zip? 
 
1 2 3 4 5  
UE6.     opening a jar? 
 
1 2 3 4 5  
L2.        speaking? 1 2 3 4 5   
L3         speaking clearly enough to use the 
h ? 
1 2 3 4 5  
L5.        getting other people to understand you? 1 
 
2 3 4 5  
L6.        finding the word you wanted to say? 1 
 
2 3 4 5  
L7.        getting other people to understand you 
even when you repeated yourself? 
1 
 
2 3 4 5  
 
DURING THE PAST WEEK: 
Item ID Did you 
(Repeat before each item or as 
necessary) 
Definitely yes Mostly 
yes 
Not sure Mostly 
no 
Definitely 
no 
Physical  Comm. Psycho-
social 
T4.
 
have to write things down to remember 
them, (or ask somebody else to write 
things down for you to remember)? 
1 2 3 4 5    
T5.        find it hard to make decisions? 1 2 3 4 5  
P1.
 
feel irritable? 1 2 3 4 5  
P3.
 
feel that your personality has changed? 1 2 3 4 5  
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MD2.
 
feel discouraged about your future? 1 2 3 4 5  
MD3.
 
have no interest in other people or 
activities? 
1 2 3 4 5  
MD6.
 
feel withdrawn from other people? 1 2 3 4 5  
MD7.
 
have little confidence in yourself? 1 2 3 4 5  
E2.        feel tired most of the time? 1 2 3 4 5  
E3.        have to stop and rest often during the 
day? 
1 2 3 4 5  
E4.        feel too tired to do what you wanted to 
do? 
1 2 3 4 5  
FR7.      feel that you were a burden to your 
family? 
1 2 3 4 5  
FR9.      feel that your language problems 
interfered with your family life? 
1 2 3 4 5   
SR1.
 
go out less often than you would like? 1 2 3 4 5   
SR4.
 
do your hobbies and recreation less 
often than you would like? 
1 2 3 4 5  
SR5.
 
see your friends less often than you 
would like? 
1 2 3 4 5  
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SR7.      feel that your physical condition 
interfered with your social life? 
1 2 3 4 5    
SR8.     feel that your language problems 
interfered with your social life? 
1 2 3 4 5    
 SAQOL-39g Mean score Add all items and divide by 39  
 Physical score (SC items + M items + W items + UE 
items) / 16 
   
 Communication score (L items + FR9 + SR8) / 7    
 Psychosocial score (T items + P items + MD items + E items + FR7 + 
SR1+SR4+SR5+SR7) / 16 
 
 
1. During administration: For each item, circle number that correspondents to respondent’s choice 
2. To calculate domain scores: Transfer each number to shaded area in same row.  Average shaded boxes per column 
to calculate domain scores 
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Appendix I.1: Demographic and Medical Information- within 24 hours 
Subject Number:  _______________________________ 
DOB: _________________________       Age: ____________      Gender (Circle one):       M       F 
Race: _______________________ 
Level of education: ___________________________________________________ 
Stroke Location: ______________________________    Hours/days post onset: 
___________________ 
Lesion Size: _______________________________ 
Time from onset to initiation of tPA: ________________________________ 
Ambulation at time of d/c from acute care (Circle one)  
Non-ambulatory             With two person assist            With one person assist           With 
equipment               Independent 
 
Medications 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
Co-morbidities 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
NIHSS scores (for daily scores- enter lowest for each day) 
On admission- prior to intervention  
First NIHSS 24 hours after intervention  
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Appendix I.2: Demographic and Medical Information- 1 week 
Subject Number:  _______________________________ 
DOB: _________________________       Age: ____________      Gender (Circle one):       M       F 
Stroke Location: ______________________________    Hours/days post onset: _____________ 
 
Amount of SLP intervention  
Total Hours: ___________________________ 
Number of days: ___________________________ 
 
Amount of PT intervention  
Total Hours: ___________________________ 
Number of days: ___________________________ 
 
Amount of OT intervention  
Total Hours: ___________________________ 
Number of days: ___________________________ 
 
Ambulation abilities at time of evaluation (Circle one)  
Non-ambulatory             With two person assist            With one person assist           With 
equipment               Independent 
 
NIHSS scores (for daily scores- enter lowest for each day) 
On admission- prior to intervention  
First NIHSS 24 hours after intervention  
On discharge from acute care  
 
 
108 
 
Appendix I.3: Demographic and Medical Information- 2 week timepoint 
Subject Number:  _______________________________ 
DOB: _________________________       Age: ____________      Gender (Circle one):       M       F 
Stroke Location: _________________________   Hours/days post onset: ___________________ 
 
Amount of SLP intervention  
Total Hours: ___________________________ 
Number of days: ___________________________ 
 
Amount of PT intervention  
Total Hours: ___________________________ 
Number of days: ___________________________ 
 
Amount of OT intervention  
Total Hours: ___________________________ 
Number of days: ___________________________ 
 
Ambulation abilities at time of evaluation (Circle one)  
Non-ambulatory             With two person assist            With one person assist           With 
equipment               Independent 
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Appendix I.4: Demographic and Medical Information-3 month timepoint 
Subject Number:  _______________________________ 
DOB: _________________________       Age: ____________      Gender (Circle one):       M       F 
Stroke Location: ______________________________    Hours/days post onset: 
___________________ 
 
Amount of SLP intervention  
Total Hours: ___________________________ 
Number of days: ___________________________ 
 
Amount of PT intervention  
Total Hours: ___________________________ 
Number of days: ___________________________ 
 
Amount of OT intervention  
Total Hours: ___________________________ 
Number of days: ___________________________ 
 
Ambulation abilities at time of evaluation (Circle one)  
Non-ambulatory             With two person assist            With one person assist           With 
equipment               Independent 
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Appendix J: Charlson Comorbidity Index (CCI) 
 
Diagnosis Weight 
Myocardial Infarction 1 
Congestive Heart Failure 1 
Peripheral Vascular Disease  1 
Dementia 1 
Chronic Pulmonary Disease 1 
Connective Tissue Disease 1 
Ulcer Disease 1 
Mild Liver Disease 1 
Diabetes 1 
Diabetes with End organ damage 2 
Moderate or Severe Renal Disease 2 
Non-metastatic solid tumor 2 
Leukemia 2 
Lyphoma, Multiple myeloma 2 
Metastatic Tumor 6 
AIDS 6 
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Appendix K: National Institute of Health Stroke Scale 
1a.  Level of Consciousness: The investigator must choose a 
response if a full evaluation is prevented by such obstacles as an 
endotracheal tube, language barrier, orotracheal trauma/bandages.  A 
3 is scored only if the patient makes no movement (other than reflexive 
posturing) in response to noxious stimulation.  
0 =    Alert; keenly responsive. 
1 = Not alert; but arousable by minor stimulation to obey, answer, 
or respond. 
2 = Not alert; requires repeated stimulation to attend, or is 
obtunded and requires strong or painful stimulation to make 
movements (not stereotyped). 
3 = Responds only with reflex motor or autonomic effects or totally 
unresponsive, flaccid, and areflexic. 
______  
1b.  LOC Questions:  The patient is asked the month and his/her age.  
The answer must be correct - there is no partial credit for being close.  
Aphasic and stuporous patients who do not comprehend the questions 
will score 2.  Patients unable to speak because of endotracheal 
intubation, orotracheal trauma, severe dysarthria from any cause, 
language barrier, or any other problem not secondary to aphasia are 
given a 1.  It is important that only the initial answer be graded and that 
the examiner not "help" the patient with verbal or non-verbal cues.  
0 =  Answers both questions correctly. 
1 =  Answers one question correctly. 
2 =  Answers neither question correctly. 
______  
1c.  LOC Commands:  The patient is asked to open and close the 
eyes and then to grip and release the non-paretic hand.  Substitute 
another one step command if the hands cannot be used.  Credit is 
given if an unequivocal attempt is made but not completed due to 
weakness.  If the patient does not respond to command, the task 
should be demonstrated to him or her (pantomime), and the result 
scored (i.e., follows none, one or two commands).  Patients with 
trauma, amputation, or other physical impediments should be given 
suitable one-step commands.  Only the first attempt is scored.  
0 = Performs both tasks correctly. 
1 = Performs one task correctly. 
2 = Performs neither task correctly. ______  
2. Best Gaze:  Only horizontal eye movements will be tested. 
Voluntary or reflexive (oculocephalic) eye movements will be scored, 
but caloric testing is not done.  If the patient has a conjugate deviation 
of the eyes that can be overcome by voluntary or reflexive activity, the 
score will be 1.  If a patient has an isolated peripheral nerve paresis 
(CN III, IV or VI), score a 1.  Gaze is testable in all aphasic patients.  
Patients with ocular trauma, bandages, pre-existing blindness, or other 
disorder of visual acuity or fields should be tested with reflexive 
movements, and a choice made by the investigator. Establishing eye 
contact and then moving about the patient from side to side will 
occasionally clarify the presence of a partial gaze palsy.   
0 = Normal. 
1 = Partial gaze palsy; gaze is abnormal in one or both eyes, but 
forced deviation or total gaze paresis is not present. 
2 = Forced deviation, or total gaze paresis not overcome by the 
oculocephalic maneuver. 
______  
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3. Visual:  Visual fields (upper and lower quadrants) are tested by 
confrontation, using finger counting or visual threat, as appropriate. 
Patients may be encouraged, but if they look at the side of the moving 
fingers appropriately, this can be scored as normal.  If there is unilateral 
blindness or enucleation, visual fields in the remaining eye are scored.  
Score 1 only if a clear-cut asymmetry, including quadrantanopia, is found.  
If patient is blind from any cause, score 3. Double simultaneous 
stimulation is performed at this point.  If there is extinction, patient 
receives a 1, and the results are used to respond to item 11.  
0 = No visual loss.  
1 = Partial hemianopia.  
2 = Complete hemianopia.  
3 = Bilateral hemianopia (blind including cortical blindness).  
______  
4. Facial Palsy:  Ask – or use pantomime to encourage – the patient to 
show teeth or raise eyebrows and close eyes.  Score symmetry of 
grimace in response to noxious stimuli in the poorly responsive or non-
comprehending patient.  If facial trauma/bandages, orotracheal tube, tape 
or other physical barriers obscure the face, these should be removed to 
the extent possible.  
0 = Normal symmetrical movements.  
1 = Minor paralysis (flattened nasolabial fold, asymmetry on 
smiling).  
2 = Partial paralysis (total or near-total paralysis of lower face).  
3 = Complete paralysis of one or both sides (absence of facial 
movement in the upper and lower face).  
______  
5. Motor Arm:  The limb is placed in the appropriate position: extend the 
arms (palms down) 90 degrees (if sitting) or 45 degrees (if supine).  Drift 
is scored if the arm falls before 10 seconds.  The aphasic patient is 
encouraged using urgency in the voice and pantomime, but not noxious 
stimulation.  Each limb is tested in turn, beginning with the non-paretic 
arm.  Only in the case of amputation or joint fusion at the shoulder, the 
examiner should record the score as untestable (UN), and clearly write 
the explanation for this choice.  
0 =  No drift; limb holds 90 (or 45) degrees for full 10 seconds.  
1 =  Drift; limb holds 90 (or 45) degrees, but drifts down before full 10 
seconds; does not hit bed or other support.  
2 =  Some effort against gravity; limb cannot get to or maintain (if 
cued) 90 (or 45) degrees, drifts down to bed, but has some effort 
against gravity.  
3 =  No effort against gravity; limb falls.  
4 =  No movement.  
  UN = Amputation or joint fusion, explain:  _____________________  
5a.  Left Arm    
5b.  Right Arm   
______  
______  
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6. Motor Leg:  The limb is placed in the appropriate position:  hold the 
leg at 30 degrees (always tested supine).  Drift is scored if the leg falls 
before 5 seconds.  The aphasic patient is encouraged using urgency in 
the voice and pantomime, but not noxious stimulation. Each limb is tested 
in turn, beginning with the non-paretic leg.  Only in the case of amputation 
or joint fusion at the hip, the examiner should record the score as 
untestable (UN), and clearly write the explanation for this choice.  
0 =  No drift; leg holds 30-degree position for full 5 seconds.  
1 =  Drift; leg falls by the end of the 5-second period but does not hit 
bed.     
2 =  Some effort against gravity; leg falls to bed by 5 seconds, but has 
some effort against gravity.  
3 =  No effort against gravity; leg falls to bed immediately.  
4 =  No movement.  
  UN = Amputation or joint fusion, explain: ________________ 6a.  
Left Leg  
6b.  Right Leg  
______  
  ______  
7. Limb Ataxia:  This item is aimed at finding evidence of a unilateral 
cerebellar lesion.  Test with eyes open.  In case of visual defect, ensure 
testing is done in intact visual field.  The finger-nose-finger and heel-shin 
tests are performed on both sides, and ataxia is scored only if present out 
of proportion to weakness.  Ataxia is absent in the patient who cannot 
understand or is paralyzed.  Only in the case of amputation or joint fusion, 
the examiner should record the score as untestable (UN), and clearly 
write the explanation for this choice.  In case of blindness, test by having 
the patient touch nose from extended arm position.  
0 = Absent.  
1 = Present in one limb.  
2 = Present in two limbs.  
 UN = Amputation or joint fusion, explain:  ________________  
______  
8. Sensory:  Sensation or grimace to pinprick when tested, or withdrawal 
from noxious stimulus in the obtunded or aphasic patient. Only sensory 
loss attributed to stroke is scored as abnormal and the examiner should 
test as many body areas (arms [not hands], legs, trunk, face) as needed 
to accurately check for hemisensory loss.  A score of 2, “severe or total 
sensory loss,” should only be given when a severe or total loss of 
sensation can be clearly demonstrated. Stuporous and aphasic patients 
will, therefore, probably score 1 or 0. The patient with brainstem stroke 
who has bilateral loss of sensation is scored 2.  If the patient does not 
respond and is quadriplegic, score 2. Patients in a coma (item 1a=3) are 
automatically given a 2 on this item.  
0 = Normal; no sensory loss.  
1 = Mild-to-moderate sensory loss; patient feels pinprick is less 
sharp or is dull on the affected side; or there is a loss of 
superficial pain with pinprick, but patient is aware of being 
touched.  
2 = Severe to total sensory loss; patient is not aware of being 
touched in the face, arm, and leg.  
______  
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9. Best Language:  A great deal of information about comprehension will 
be obtained during the preceding sections of the examination. For this 
scale item, the patient is asked to describe what is happening in the 
attached picture, to name the items on the attached naming sheet and to 
read from the attached list of sentences. Comprehension is judged from 
responses here, as well as to all of the commands in the preceding 
general neurological exam.  If visual loss interferes with the tests, ask the 
patient to identify objects placed in the hand, repeat, and produce speech.  
The intubated patient should be asked to write. The patient in a coma 
(item 1a=3) will automatically score 3 on this item.  The examiner must 
choose a score for the patient with stupor or limited cooperation, but a 
score of 3 should be used only if the patient is mute and follows no one-
step commands.  
0 = No aphasia; normal.  
1 =  Mild-to-moderate aphasia; some obvious loss of fluency or facility 
of comprehension, without significant limitation on ideas expressed or 
form of expression.  Reduction of speech and/or comprehension, 
however, makes conversation about provided materials difficult or 
impossible.  For example, in conversation about provided materials, 
examiner can identify picture or naming card content from patient’s 
response.  
2 = Severe aphasia; all communication is through fragmentary 
expression; great need for inference, questioning, and guessing by the 
listener.  Range of information that can be exchanged is limited; 
listener carries burden of communication.  Examiner cannot identify 
materials provided from patient response.  
3 = Mute, global aphasia; no usable speech or auditory 
comprehension.  
______  
10. Dysarthria: If patient is thought to be normal, an adequate sample of 
speech must be obtained by asking patient to read or repeat words from 
the attached list.  If the patient has severe aphasia, the clarity of 
articulation of spontaneous speech can be rated.  Only if the patient is 
intubated or has other physical barriers to producing speech, the 
examiner should record the score as untestable (UN), and clearly write 
an explanation for this choice.  Do not tell the patient why he or she is 
being tested.  
0 = Normal.  
1 = Mild-to-moderate dysarthria; patient slurs at least some 
words and, at worst, can be understood with some difficulty.  
2 = Severe dysarthria; patient's speech is so slurred as to be 
unintelligible in the absence of or out of proportion to any 
dysphasia, or is mute/anarthric.  
UN = Intubated or other physical barrier, 
explain:_____________________________  
______  
11. Extinction and Inattention (formerly Neglect):  Sufficient  0 = No abnormality.  
information to identify neglect may be obtained during the prior  
      testing.  If the patient has a severe visual loss preventing visual   1 = Visual, tactile, auditory, spatial, or personal inattention  
double simultaneous stimulation, and the cutaneous stimuli are or  
extinction to bilateral simultaneous stimulation in one ______ normal,  
the score is normal.  If the patient has aphasia but does of the sensory 
modalities. appear to attend to both sides, the score is normal.  The presence of  
      visual spatial neglect or anosagnosia may also be taken as evidence   2 = Profound hemi-inattention or extinction to more than  
of abnormality.                                                                                               one modality 
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